
    <html>
    <head><title>CCO.TO — algorithm buy 9d</title>
<style>
body {
  font-family: Arial, sans-serif;
  margin: 20px;
}
.container {
  display: grid;
  grid-template-columns: 50% 50%;
  grid-template-rows: auto auto;
  gap: 20px;
}
img {
  width: 100%;
  height: auto;
  max-height: 400px;
  border: 1px solid #ccc;
  object-fit: contain;
}

.cell {
  padding: 10px;
}
.table-scroll {
  max-height: 400px;
  overflow-y: auto;
  border: 1px solid #aaa;
}
table {
  width: 100%;
  border-collapse: collapse;
}
th, td {
  border: 1px solid #aaa;
  padding: 5px;
  text-align: left;
  font-size: 14px;
}
.negative {
  background: linear-gradient(to right, #ffdddd, white);
}
.positive {
  background: linear-gradient(to right, white, #ddffdd);
}
.pos-light  { background: #e6ffe6; }  
.pos-mid    { background: #99ff99; }  
.pos-strong { background: #33cc33; }   

.neg-light  { background: #ffe6e6; }   
.neg-mid    { background: #ff9999; }   
.neg-strong { background: #ff3333; }   

h2 { border-bottom: 2px solid #444; }
<script>
function toggleText(id) {
  const moreText = document.getElementById(id);
  const btn = document.getElementById(id + "_btn");

  if (moreText.style.display === "none") {
    moreText.style.display = "inline";
    btn.innerText = " Show less";
  } else {
    moreText.style.display = "none";
    btn.innerText = " Show more";
  }
}
</script>
</style>
</head>
    <body>
    <h2><span style='color:#1e66f5; font-weight:900; margin-right:10px;'>quarterly earnings d</span> CCO.TO <span style='margin-left:8px; padding:2px 6px; border:1px solid #0a0; border-radius:6px; background:#eaffea; color:#0a0; font-weight:700;'>algorithm buy 9d</span> 
        <span style='font-weight:normal; font-size: 18px;'>(10d - quarterly earnings)</span>
        <span style='color:darkred; font-weight:bold; font-size: 20px;'> 3D NEG</span>
        <a href='https://finance.yahoo.com/chart/CCO.TO?interval=1mo' target='_blank'>Yahoo</a>
        <span style='font-weight:600;'>  bought (71.01-75.92) —  — now: 111.95  — ATR_low: 109.69 (cta 8 days)</span>
    </h2>

    <div class="container">
        <div class="cell"><div style='display:flex; gap:10px; align-items:flex-start'>  <div style='flex:0 0 50%'><a href='https://vosorin.github.io/100__2025_06_public/RAPORT/C_ZOOM_CCO.TO_NEWS.jpg' target='_blank'>    <img src='C_ZOOM_CCO.TO_NEWS.jpg' alt='C_ZOOM_CCO.TO_NEWS.jpg'></a></div>  <div style='flex:0 0 50%'><a href='https://vosorin.github.io/100__2025_06_public/RAPORT/C_CCO.TO_BAND.jpg' target='_blank'>    <img src='C_CCO.TO_BAND.jpg' alt='C_CCO.TO_BAND.jpg'></a></div></div></div>
        <div class="cell"><div style='display:flex; gap:10px; align-items:flex-start'>  <div style='flex:0 0 50%'><a href='https://vosorin.github.io/100__2025_06_public/RAPORT/B_ZOOM_CCO.TO_ALL.jpg' target='_blank'>    <img src='B_ZOOM_CCO.TO_ALL.jpg' alt='B_ZOOM_CCO.TO_ALL.jpg'></a></div>  <div style='flex:0 0 50%'><a href='https://vosorin.github.io/100__2025_06_public/RAPORT/B_CCO.TO_BAND.jpg' target='_blank'>    <img src='B_CCO.TO_BAND.jpg' alt='B_CCO.TO_BAND.jpg'></a></div></div></div>
        <div class="cell"><div style='display:flex;gap:10px;align-items:flex-start'><a href="https://vosorin.github.io/100__2025_06_public/RAPORT/A_CCO.TO_3d_neg_ZOOM.png" target="_blank"><img src="A_CCO.TO_3d_neg_ZOOM.png" alt="A_CCO.TO_3d_neg_ZOOM.png"></a><a href="https://vosorin.github.io/100__2025_06_public/RAPORT/A_CCO.TO_3d_neg.jpg" target="_blank"><img src="A_CCO.TO_3d_neg.jpg" alt="A_CCO.TO_3d_neg.jpg"></a></div></div>
        <div class="cell"><div class='table-scroll'><table><tr><th>Date</th><th>Score</th><th>AMR</th><th>Type</th><th>Summary</th><th>Links</th></tr><tr class='pos-light'><td>2025-11-18</td><td>0.35</td><td></td><td>quarterly earnings</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Here's a breakdown of the scoring: quarterly or annual results: Missed estimates (-0.2). This is a significant negative. major dividend change: Increased dividend (25.0% yield) (+0.2). This is a strong positive signal. management changes: No relevant information (0). guidance updates: FY 2025 EPS guidance set (+0.1). This provides some visibility into the future. analyst meetings: "Moderate Buy" consensus and price target upgrade from Goldman Sachs (+0.1). Analyst rating changes generally receive low scores, but the consensus and specific upgrade are slightly positive. buyback programs: No relevant information (0). accretive to DCF per share: No explicit confirmation, but analysts' price targets imply some accretion (0.05). credit rating changes: No relevant information (0). large contract wins or losses: No relevant information (0). strategic partnerships or joint ventures: No relevant information (0). revenue decline: Mentioned as something investors should monitor (-0.05). This is a potential concern. Note: The institutional buying activity is largely backward-looking and doesn't necessarily indicate future performance, so it's not factored into the score. The missed earnings estimate is the most significant negative factor, while the dividend increase is the most significant positive. --- <br> - Cameco (CCJ) is attracting institutional interest with several firms initiating or increasing positions. While recent earnings missed estimates, analysts remain largely positive, with a "Moderate Buy" consensus and a $113.75 price target. The increased dividend is a positive signal, but investors should monitor the revenue decline. <br><br>*** REZUMAT *** - Vise Technologies initiated a new position in Cameco (CCJ), acquiring 3,199 shares. - Manchester Capital Management increased its stake by 100%, owning 600 shares. - Dagco Inc. purchased a $28,000 stake in Cameco in Q1. - SVB Wealth LLC acquired a $29,000 stake in Q1. - Trust Co. of Vermont increased holdings by 1,029.4%, now owning 384 shares. - Hilltop National Bank purchased a new $30,000 position in Q2. - 70.21% of CCJ stock is owned by institutional investors. - Scotiabank reaffirmed an "outperform" rating on October 29th. - Wall Street Zen cut rating from "buy" to "hold" on November 8th. - Goldman Sachs boosted price target from $95.00 to $109.00 on October 29th. - Consensus rating is "Moderate Buy" with a $113.75 price target. - CCJ opened at $82.97 on Tuesday, 52-week range $35.00-$110.15. - Q3 earnings per share were $0.05, missing estimates by $0.17. - Revenue was $313.74 million, below the $531.72 million estimate. - FY 2025 EPS guidance set. Analysts forecast 1.27 EPS for the year. - Cameco increased annual dividend to $0.24, a 25.0% yield. - Payout ratio is 19.77%. Ex-dividend date is December 1st.   (gemma3:12b-it-q4_K_M on 2025-11-18 22:44:42)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-vise-technologies-inc-takes-position-in-cameco-corporation-ccj-2025-11-18/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-17</td><td>0.30</td><td>30</td><td>Joint venture/Strategic partnership</td><td>0.3 local feel              __   CCO.TO __    -> i:0.5<-                     **   ** 2025-12-21 **   <br><br>** 2025-12-21  Joint venture/Strategic partnership ***<br>FEELING: total score +0.3 Reasoning: Strategic partnerships or joint ventures: The partnership with Denison Mines is a significant event. The potential for synergy is clear, as it brings funding and expertise to the Russell Lake Uranium Project. This contributes a +0.3 score. Industry tailwinds: The news highlights positive industry trends (US uranium demand, data center power needs). While these are supportive, they are not directly attributable to Skyharbour's actions and therefore receive a lower weight. Capital raises: The agreement includes up to CAD $61.5 million consideration, which can be seen as a form of capital inflow. This contributes a small positive impact. Deferred consideration: The deferred consideration payable by December 2025, in cash or shares, introduces some uncertainty, slightly reducing the positive impact. Low score for promotional language and backward-looking data: The news contains some promotional language, which is discounted. --- <br> - Skyharbour Resources is poised to benefit from a strategic partnership with Denison Mines, securing significant funding and expertise for Russell Lake Uranium Project. This agreement, coupled with broader industry tailwinds like US uranium demand and data center power needs, presents a potentially lucrative opportunity for investors. <br><br>*** REZUMAT *** - Skyharbour Resources (SYH/SYHBF) enters strategic partnership with Denison Mines (DNN/DML). - Agreement includes up to CAD $61.5 million consideration for Russell Lake Uranium Project. - US expanding critical minerals list to include uranium, reducing foreign reliance. - Tech giants (Microsoft, Alphabet, Amazon) seeking nuclear power for data centers. - Denison to acquire 20-70% interest in Russell Lake via four joint ventures. - Skyharbour retains 80% ownership at Russell Lake (RL) claims (53,592 hectares). - Denison commits $4 million in exploration over two years at Wheeler North & Getty East. - Closing expected on or before December 21, 2025, with $2 million upfront payment. - Deferred consideration of $16 million payable by December 2025, in cash or shares.   (gemma3:12b-it-q4_K_M on 2025-11-17 22:53:05)</td><td><a href='https://www.theglobeandmail.com/investing/markets/stocks/NXE-N/pressreleases/36159382/five-top-uranium-stocks-to-buy-heading-into-new-year-2026/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-17</td><td>0.35</td><td></td><td>quarterly earnings</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Here's a breakdown of the scoring: Institutional Buying Activity: +0.1 (Significant institutional buying generally indicates positive sentiment and confidence in the company's future, but the effect is moderate) Quarterly Results Missed Expectations: -0.2 (Earnings miss is negative, but the impact is somewhat mitigated by other positive factors) Dividend Increase: +0.2 (A 25.0% increase is a substantial positive, triggering the +0.2 score) Analyst Ratings: 0 (While there are differing ratings, there's no clear consensus, so the impact is minimal) FY 2025 EPS Guidance: +0.05 (Guidance being set is a positive sign, but the lack of specifics limits the score) Backward-Looking Data/Promotional Language: 0 (The news includes information about past performance and ranges, which are given a very low score) --- <br> - Cameco is experiencing significant institutional buying activity, with several firms increasing their stakes. While recent earnings missed expectations, analysts maintain a generally positive outlook, supported by a dividend increase. Investors should monitor future earnings reports and overall market conditions. <br><br>*** REZUMAT *** - Allworth Financial LP increased Cameco holdings by 30.6% in Q2, acquiring 1,060 shares. - Fidelis Capital Partners LLC invested $260,000 in Cameco during Q2. - Summit X LLC acquired a $234,000 stake in Cameco during Q2. - King Luther Capital Management Corp boosted stake by 0.4%, owning 994,027 shares. - DJE Kapital AG increased position by 186.9%, acquiring 56,700 shares. - Acadian Asset Management LLC increased stake by 1,428.6%, acquiring 914,300 shares. - 70.21% of Cameco stock is held by institutional investors. - UBS set a neutral rating and $140 target price. - CLSA set outperform rating and $102 price target. - Average analyst price target is $113.75. - Shares opened at $84.69 with a 1-year range of $35.00 - $110.15. - Q3 earnings were $0.05 EPS, missing the $0.22 estimate. - Revenue was $313.74 million, below the $531.72 million estimate. - FY 2025 EPS guidance set. - Annual dividend increased to $0.24 per share, a 25.0% yield.   (gemma3:12b-it-q4_K_M on 2025-11-17 22:31:49)</td><td><a href='https://www.defenseworld.net/2025/11/17/cameco-corporation-ccj-shares-bought-by-allworth-financial-lp.html' target='_blank'>Link</a></td></tr><tr class='pos-mid'><td>2025-11-17</td><td>0.45</td><td>25</td><td>Major dividend change</td><td>0.45 local feel              __   CCO.TO __    -> i:0.65<-                     **   ** 2025-12-16 **   <br><br>** 2025-12-16  Major dividend change ***<br>FEELING: total score 0.45 Here's a breakdown of the scoring: Institutional Investor Activity: (+0.2) - Several institutional investors increasing positions is a positive signal of confidence. Missed Q3 Earnings & Revenue: (-0.2) - Missing earnings and revenue estimates is a negative, but the overall impact is lessened by other positive factors. Positive Analyst Ratings: (+0.1) - "Outperform" and "Buy" ratings are mildly positive. Dividend Increase: (+0.2) - A 25.0% increase in the annual dividend is a significant positive event. FY2025 Guidance: (0) - Mentioning guidance is neutral as it requires further analysis. Analyst Target Price: (0) - Analyst target prices are generally low impact unless there's a clear consensus. Backward-Looking Data: (0) - The P/E ratio and past performance data are not factored into the score. --- <br> - Several institutional investors increased their positions in Cameco (CCJ), signaling confidence. While the company missed Q3 earnings estimates and revenue fell, positive analyst ratings and a dividend increase suggest potential for future growth. Investors should monitor FY2025 guidance. <br><br>*** REZUMAT *** - Massachusetts Financial Services Co. increased its stake in CCJ by 15.2% during Q2. - Manchester Capital Management boosted its CCJ stake by 100% in Q1. - Dagco Inc. acquired a new stake in CCJ valued at ~$28,000 in Q1. - SVB Wealth LLC acquired a new position in CCJ worth ~$29,000 in Q1. - Trust Co. of Vermont increased stake by 1,029.4% in Q2, now owning 384 shares. - Hilltop National Bank acquired a new stake in CCJ valued at ~$30,000 in Q2. - 70.21% of CCJ stock is owned by institutional investors. - BMO Capital Markets and Goldman Sachs have "outperform" and "buy" ratings. - Average analyst target price is $113.75, with a "Moderate Buy" consensus. - CCJ opened at $84.69, has a market cap of $36.87B, and a 97.34 P/E ratio. - Q3 EPS was $0.05, missing estimates by $0.17; revenue was $313.74M, below $531.72M. - FY 2025 guidance set, analysts expect 1.27 EPS for the current year. - Annual dividend increased to $0.24, payable December 16th, representing a 25.0% yield.   (gemma3:12b-it-q4_K_M on 2025-11-17 22:28:59)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-cameco-corporation-ccj-shares-purchased-by-massachusetts-financial-services-co-ma-2025-11-17/' target='_blank'>Link</a></td></tr><tr class='pos-mid'><td>2025-11-16</td><td>0.41</td><td>25</td><td>Major dividend change</td><td>0.41 local feel              __   CCO.TO __    -> i:0.61<-                     **   ** 2025-12-16 **   <br><br>** 2025-12-16  Major dividend change ***<br>FEELING: total score 0.41 Here's a breakdown of the scoring: quarterly or annual results: Missed earnings estimates (-0.2). dividend change: Increased dividend (25.0% yield) (+0.2). analyst meetings: "Moderate Buy" rating (+0.1). guidance updates: FY 2025 EPS guidance of 1.27 (+0.1). share ownership changes: While there are changes in ownership, these are generally neutral unless they signal a broader trend. The mixed signals (increase by some, decrease by others) cancel each other out. (0) buyback programs: No mention of buybacks (0). regulatory changes: No mention of regulatory changes (0). Rationale: The missed earnings are a negative, but the dividend increase and positive analyst rating provide offsetting positives. The guidance update is also a positive signal. The ownership changes are too mixed to have a significant impact. --- <br> - Cameco faces mixed signals. While several institutions increased their stake, Banco Bilbao Vizcaya Argentaria reduced theirs. Recent earnings missed estimates, and analysts have adjusted price targets, but a dividend increase and a "Moderate Buy" rating suggest potential for investors. <br><br>*** REZUMAT *** - Banco Bilbao Vizcaya Argentaria sold 6,141 shares, reducing stake by 6.6% in Q2. - Manchester Capital Management increased stake by 100%, owning 600 shares. - Dagco Inc. purchased a new stake valued at $28,000 in Q1. - SVB Wealth LLC acquired a new stake worth $29,000 in Q1. - Trust Co. of Vermont increased holdings by 1,029.4%, now owning 384 shares. - Analysts have a consensus target price of $113.75, with a "Moderate Buy" rating. - Cameco missed Q3 earnings estimates by $0.17, reporting $0.05 EPS. - Revenue was $313.74 million, below the $531.72 million estimate. - FY 2025 guidance set, with expected EPS of 1.27. - Annual dividend increased to $0.24, a 25.0% yield.   (gemma3:12b-it-q4_K_M on 2025-11-16 20:09:12)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-cameco-corporation-ccj-shares-sold-by-banco-bilbao-vizcaya-argentaria-sa-2025-11-16/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-16</td><td>0.35</td><td>25</td><td>Major dividend change</td><td>0.35 local feel              __   CCO.TO __    -> i:0.55<-                     **   ** 2025-12-16 **   <br><br>** 2025-12-16  Major dividend change ***<br>FEELING: total score 0.35 Here's a breakdown of the scoring: Institutional Investment Increase: +0.2 (Significant institutional investment is generally positive, indicating confidence. Multiple institutions increasing stakes is a strong signal.) Analyst Ratings: +0.05 (Moderate Buy rating is mildly positive, but the average target price isn't significantly above the current price, so the impact is limited.) Missed Earnings & Revenue Decline: -0.15 (Missing earnings and lower-than-expected revenue are negative, impacting investor sentiment.) Dividend Increase: +0.1 (A 25% dividend increase is a substantial positive, signaling confidence and returning value to shareholders. This is a significant contributor.) FY 2025 EPS Guidance: +0.05 (Setting guidance is a positive sign, indicating forward-looking visibility, though the details of the guidance aren't provided.) Backward-Looking Data/Promotional Language: 0 (The news includes information about past investments and mentions the company's role in electricity generation, which are low-impact.) --- <br> - Cameco (CCJ) is experiencing increased institutional investment and positive analyst ratings, though recent earnings missed expectations and revenue declined. The company's dividend increase signals confidence, but investors should monitor future earnings reports and uranium market trends. <br><br>*** REZUMAT *** - Y.D. More Investments Ltd. purchased 17,500 shares ($1.299M) of CCJ in Q2. - Rockefeller Capital Management increased stake by 22.3%, owning 124,345 shares ($9.23M). - Westwood Holdings Group bought a $500,000 stake in Q2. - Creative Planning boosted holdings by 3.0%, owning 63,884 shares ($4.742M). - Pinnbrook Capital Management LP invested $3.679M in Q2. - Massachusetts Financial Services Co. MA increased holdings by 15.2%, owning 2,553,523 shares ($189.548M). - 70.21% of CCJ stock is owned by institutional investors. - Analysts have a "Moderate Buy" rating and average target price of $113.75. - Q3 earnings missed estimates ($0.05 vs $0.22) with $313.74M revenue (vs $531.72M expected). - FY 2025 EPS guidance set. - Annual dividend increased to $0.24 (25% yield), paid on Dec 16. - Company provides uranium for electricity generation.   (gemma3:12b-it-q4_K_M on 2025-11-16 20:08:08)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-17500-shares-in-cameco-corporation-ccj-purchased-by-yd-more-investments-ltd-2025-11-16/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-14</td><td>0.20</td><td></td><td>quarterly earnings</td><td>0.2 local feel              __   CCO.TO __    -> i:0.2<-                      <br><br>FEELING: total score +0.2 Reasoning: The news primarily revolves around analyst price target increases and "Buy" ratings. This falls under "analyst meetings" and generally indicates a positive outlook. While a consensus "Buy" rating isn's a massive signal, it does suggest a positive sentiment. The recent stock price decline is noted, but the overall tone remains bullish. The price target increases themselves are a positive signal, suggesting analysts anticipate future growth. The Q3 revenue figure is backward-looking and receives a very low score. The trading volume is also not a significant factor. --- <br> - Cameco (CCO) is receiving significant positive attention from analysts, with multiple price target increases and "Buy" ratings. While the stock traded down recently, the overall sentiment is bullish, suggesting potential for upside. Investors should consider the increased price targets and analyst recommendations. <br><br>*** REZUMAT *** - TD Securities raised Cameco's (CCO) price target to C$150.00 from C$142.00. - Canaccord Genuity increased target to C$115.00 on July 30th. - UBS Group rates CCO as "Hold". - Desjardins boosted target to C$110.00 on August 1st. - Bank of America raised target to C$175.00 on October 29th. - Royal Bank Of Canada increased target to C$160.00 on October 31st. - Consensus rating is "Buy" with a target price of C$141.08. - Stock traded down C$8.68 to C$121.00 on Thursday. - 848,285 shares traded, below the average of 1,243,320. - 52-week range: C$49.75 - C$153.59. - Market cap: C$52.68 billion. - Q3 Revenue: C$614.56 million.   (gemma3:12b-it-q4_K_M on 2025-11-14 20:25:11)</td><td><a href='https://www.marketbeat.com/instant-alerts/td-securities-increases-cameco-tsecco-price-target-to-c15000-2025-11-13/' target='_blank'>Link</a></td></tr><tr class='neg-light'><td>2025-11-14</td><td>-0.25</td><td></td><td>quarterly earnings</td><td>-0.25 local feel              __   CCO.TO __    -> i:0.25<-                      <br><br>FEELING: total score -0.25 Breakdown: Analyst downgrade: -0.1 (Analysts' ratings generally receive a low score, but a downgrade warrants a slight negative impact) Missed earnings: -0.2 (Significant miss, directly impacting investor sentiment) Revenue decline: -0.1 (Reinforces the negative earnings news) Increased dividend: +0.2 (Positive signal, but partially offset by the negative earnings news - a 25% increase is significant) New stake acquisitions: +0.05 (Slightly positive, indicating some investor confidence, but not a major driver) FY 2025 EPS guidance: 0 (Guidance is neutral, as it's an expectation rather than a concrete update) --- <br> - Cameco (CCJ) experienced a stock price dip following an analyst downgrade and disappointing earnings. While several analysts maintain a positive outlook, the missed earnings and revenue decline warrant caution. The increased dividend is a positive signal, but investors should monitor future performance. <br><br>*** REZUMAT *** - CCJ stock down 1.5% after Royal Bank of Canada lowered price target to $150 from $160. - Trading volume declined by 2% to 4,766,617 shares. - Multiple analysts maintain "Buy" or "Outperform" ratings, with an average price target of $113.75. - Q3 saw new stake acquisitions by Financial Consulate, Armstrong, Trust Co., Hilltop, and Cullen Frost. - Q3 earnings missed estimates by $0.17 at $0.05 EPS, with revenue at $313.74M vs. $531.72M expected. - FY 2025 EPS guidance set, with analysts expecting 1.27 EPS. - Annual dividend increased to $0.24, payable December 16th, representing a 25.0% yield.   (gemma3:12b-it-q4_K_M on 2025-11-14 20:24:00)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-nyseccj-stock-price-down-15-after-analyst-downgrade-2025-11-14/' target='_blank'>Link</a></td></tr><tr class='pos-mid'><td>2025-11-14</td><td>0.55</td><td></td><td>quarterly earnings</td><td>0.55 local feel              __   CCO.TO __    -> i:0.55<-                     **   ** 2025-11-05 **   <br><br>** 2025-11-05  quarterly earnings ***<br>FEELING: total score 0.55 Here's a breakdown of the scoring: quarterly or annual results: Earnings miss (-0.3) but analysts maintain positive outlook (+0.1). Net effect: -0.2 major dividend change: Increased dividend (25% yield) (+0.2) institutional investors increasing positions: This signals confidence and is a positive sign (+0.3). The multiple increases across different firms strengthens this. analyst meetings: "Outperform" and "buy" ratings, target price increases (+0.15). product launches: FY 2025 EPS guidance set (+0.1) stock splits: N/A share consolidations: N/A lawsuits: N/A accretive to DCF per share: N/A debt restructuring / renegotiation: N/A credit rating changes: N/A buyback programs: N/A FDA or Canada Health decisions: N/A capital raises: N/A bankruptcy filings or Chapter 11 protection: N/A strategic partnerships or joint ventures: N/A large contract wins or losses: N/A cybersecurity incidents / data breaches: N/A major political actions like war or major strikes: N/A regulatory changes: N/A Negative factors: The earnings miss and revenue decline are negative, but the overall sentiment is positive due to institutional buying and analyst ratings. --- <br> - Cameco (CCJ) experienced a recent earnings miss and revenue decline, prompting a stock dip. However, several institutional investors are increasing their positions, and analysts maintain a generally positive outlook with price target increases and "buy" ratings. The increased dividend is a positive signal. <br><br>*** REZUMAT *** - Thompson Davis & CO. Inc. acquired 3,425 shares of Cameco (CCJ) valued at $254,000 in Q2. - Bison Wealth LLC increased its stake by 16.1%, owning 21,448 shares worth $1,102,000. - Envestnet Asset Management Inc. increased stake by 66.9%, owning 447,581 shares valued at $18,422,000. - Cerity Partners LLC raised holdings by 10.8%, owning 25,387 shares worth $1,045,000. - Stephens Inc. AR boosted position by 89.0%, owning 12,366 shares worth $509,000. - CWM LLC grew holdings by 43.7%, owning 6,347 shares valued at $261,000. - 70.21% of stock owned by institutional investors and hedge funds. - CCJ opened at $86.00 with a 52-week range of $35.00 - $110.15. - Q3 EPS was $0.05, missing estimates by $0.17, with revenue of $313.74 million. - FY 2025 EPS guidance set, analysts predict 1.27 EPS. - Annual dividend increased to $0.24 per share, a 25.0% yield. - Several analysts reiterated "outperform" or "buy" ratings, with Goldman Sachs raising target to $109.00. - Consensus rating is "Moderate Buy" with a target price of $113.75.   (gemma3:12b-it-q4_K_M on 2025-11-14 20:33:41)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-thompson-davis-co-inc-purchases-new-position-in-cameco-corporation-ccj-2025-11-14/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-14</td><td>0.38</td><td></td><td>quarterly earnings</td><td>0.38 local feel              __   CCO.TO __    -> i:0.38<-                      <br><br>FEELING: total score 0.38 Here's a breakdown of the scoring: quarterly or annual results: Missed earnings estimates (-0.2). This is a significant negative. major dividend change: Increased dividend by 100% (+0.2). This is a very positive signal of confidence. guidance updates: FY 2025 EPS guidance set analysts expect 1.27 EPS (+0.1). This is a slightly positive signal. buyback programs: No mention, score 0. analyst meetings: Analyst ratings are generally "Moderate Buy" (+0.05). While there was a price target decrease from UBS (-0.05), the overall sentiment remains positive. institutional investor ownership: 70.21% owned by institutional investors (0). This is a neutral factor. large contract wins or losses: No mention, score 0. strategic partnerships or joint ventures: No mention, score 0. Negative factors are partially offset by the significant dividend increase and the overall positive analyst sentiment. --- <br> - Cameco (CCJ) experienced a stock dip after missing earnings estimates, but increased its dividend by 100% to $0.24, signaling confidence. While analysts maintain a "Moderate Buy" rating with an average target price of $113.75, investors should consider the recent earnings miss. <br><br>*** REZUMAT *** - L&S Advisors Inc. bought 54,382 shares ($4.037M) of CCJ in Q2. - Manchester Capital Management increased holdings by 100% ($25K). - Dagco Inc. bought a stake valued at ~$28K in Q1. - SVB Wealth LLC acquired a position worth ~$29K in Q1. - Trust Co. of Vermont increased stake by 1029.4% ($29K). - Hilltop National Bank bought a position valued at $30K in Q2. - 70.21% of CCJ stock is owned by institutional investors. - National Bankshares rates CCJ as "outperform." - UBS decreased price target from $160 to $150, rating "outperform." - Average analyst rating is "Moderate Buy" with a $113.75 target. - CCJ opened at $86.00 on Friday, 52-week range $35.00-$110.15. - Q3 earnings: $0.05 EPS, missing estimate by $0.17; revenue $313.74M vs $531.72M. - FY 2025 EPS guidance set; analysts expect 1.27 EPS. - Increased annual dividend to $0.24 (25.0% yield), paid Dec 16. - CCJ operates in Uranium, Fuel Services, and Westinghouse segments.   (gemma3:12b-it-q4_K_M on 2025-11-14 20:35:04)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-54382-shares-in-cameco-corporation-ccj-bought-by-l-s-advisors-inc-2025-11-14/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-11</td><td>0.30</td><td></td><td>nan</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Here's a breakdown of the scoring: YTD gain & 1-year TSR (82.5%): +0.1 (Significant positive momentum, indicating market confidence) Fair value estimate (CA$146.44, undervalued by ~CA$14): +0.1 (Suggests potential for future appreciation, though the undervaluation is a matter of opinion) Projected earnings and margins driving valuation bump: +0.1 (Forward-looking, positive impact on valuation) Momentum in utility contracting is building & Expect surge in term contracting through 2045: +0.1 (Positive outlook for future revenue and growth) High P/E ratio (109.4): -0.1 (Indicates potential overvaluation and risk, offsetting some of the positive momentum) Operational challenges and project delays pose risks: -0.1 (Acknowledges potential headwinds, reducing the overall positive sentiment) Note: The "undervalued" assessment is subjective and doesn't inherently guarantee future performance. The high P/E ratio is a risk factor that needs to be considered. --- <br> - Cameco's impressive gains (76% YTD, 82.5% 1-year TSR) suggest strong market optimism. While currently deemed undervalued with a fair value of $146.44, the high P/E ratio (109.4) indicates potential overvaluation and risk if sentiment shifts. Monitor operational challenges and reactor project timelines. <br><br>*** REZUMAT *** - Cameco (CCO) shares up 8% in the past month. - YTD gain: 76%, 1-year TSR: 82.5%, 5-year TSR: 970%. - Fair value estimate: CA$146.44 (undervalued by ~CA$14). - Projected earnings and margins driving valuation bump. - P/E ratio: 109.4, significantly above peers (14 & 16.4). - Operational challenges and project delays pose risks. - Momentum in utility contracting is building. - Expect surge in term contracting through 2045.   (gemma3:12b-it-q4_K_M on 2025-11-13 05:05:41)</td><td><a href='https://simplywall.st/stocks/ca/energy/tsx-cco/cameco-shares/news/cameco-tsxcco-evaluating-valuation-after-recent-share-price' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-10</td><td>0.35</td><td></td><td>quarterly earnings</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Here's a breakdown of the scoring: quarterly or annual results: Missed earnings estimates (-0.2). This is a significant negative. dividend increase: Increased dividend by 25% (+0.2). This is a substantial increase and a positive signal. analyst ratings: Positive ratings from UBS and RBC (+0.1). While positive, the ratings themselves don't carry significant weight unless there's a broader consensus. guidance updates: FY 2025 EPS guidance (+0.1). This is a forward-looking statement, albeit reliant on analyst predictions. institutional investor activity: Several institutional investors increased their stakes (+0.1). This suggests confidence in the company's future. However, Penserra Capital Management sold shares (-0.05). missed revenue estimates: -0.05. The negative impact of missing earnings and revenue estimates is partially offset by the dividend increase and positive institutional investor activity. --- <br> - Cameco (CCJ) experienced a stock dip after missing earnings estimates, but several institutional investors increased their stakes. While the company faces revenue challenges, a dividend increase and positive analyst ratings suggest potential for future growth. Investors should monitor upcoming earnings reports and the impact of the $80 billion U.S. nuclear deal. <br><br>*** REZUMAT *** - Penserra Capital Management sold 12,973 shares, reducing holdings by 23.9% in Q2. - Vanguard Group increased stake by 1.8%, owning 17,084,358 shares ($703.295M). - Alliancebernstein L.P. grew stake by 39.3%, owning 14,048,244 shares ($578.226M). - AGF Management Ltd. increased position by 19.0%, owning 4,037,646 shares ($166.206M). - William Blair Investment Management increased stake by 15.1%, owning 3,869,291 shares ($287.217M). - Ameriprise Financial Inc. raised stake by 20.6%, owning 3,048,732 shares ($125.533M). - 70.21% of the company's stock is held by institutional investors. - UBS set a $102 target price; RBC increased to $110 with "outperform" rating. - Stock opened at $92.30, 52-week range: $35.00 - $110.15. - Q3 revenue: $313.74M, missing estimate of $531.72M; EPS $0.05, missing $0.22. - FY 2025 EPS guidance set; analysts predict 1.27 EPS. - Company increased annual dividend to $0.24 (25.0% yield), DPR 13.95%.   (gemma3:12b-it-q4_K_M on 2025-11-13 10:29:17)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-penserra-capital-management-llc-sells-12973-shares-of-cameco-corporation-ccj-2025-11-10/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-08</td><td>0.20</td><td></td><td>quarterly earnings</td><td>0.2 local feel              __   CCO.TO __    -> i:0.2<-                      <br><br>FEELING: total score: +0.2 --- <br> - Cameco’s Q4 EPS forecast trimmed to $0.40, yet analysts keep Outperform ratings and price targets near C$137–165. The stock trades close to its 50‑day MA, with strong liquidity and low debt. It remains a solid play if uranium prices recover, but watch for earnings lag. <br><br>*** REZUMAT *** - Raymond James cuts Q4 2025 EPS to $0.40 from $0.44, maintains Outperform, $150 target. - Scotiabank, National Bankshares, TD Securities, President Capital, Stifel Nicolaus all raise targets, keep Buy/Outperform ratings. - Consensus Buy, price target C$137.30; stock down 5.2%, opened C$127.47. - Market cap C$55.5B, P/E 104.48, PEG 2.22, beta 1.28; 12‑month low C$49.75, high C$153.59. - 50‑day MA C$120.27, 200‑day MA C$100.66; current ratio 2.88, quick 3.74, debt‑to‑equity 20.35. - Cameco largest uranium producer; McArthur River mine ~50% output; reduced production, buying spot market to meet contracts. - 2 Strong Buy, 12 Buy analysts; consensus Buy rating.   (gpt-oss:20b on 2025-11-10 03:52:56)</td><td><a href='https://www.marketbeat.com/instant-alerts/raymond-james-financial-forecasts-weaker-earnings-for-cameco-2025-11-07/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-08</td><td>0.20</td><td>25</td><td>major dividend change</td><td>0.2 local feel              __   CCO.TO __    -> i:0.4<-                     **   ** 2025-12-16 **   <br><br>** 2025-12-16  major dividend change ***<br>FEELING: total score: +0.2 --- <br> - Cameco's dividend hike and strong analyst support amid institutional buying suggest upside potential, but high P/E and volatility warrant caution. <br><br>*** REZUMAT *** - Titan Global cut 18% holdings, selling 8,115 shares, remaining 37,062 shares worth $2.75M. - Bison Wealth up 16.1%, now 21,448 shares valued $1.10M. - Envestnet boosted 66.9%, 447,581 shares $18.42M. - TD Private Client added $107K stake; Stratos +2.2%, 37,573 shares $1.55M. - Axxcess bought $215K stake. - 70.21% owned by institutions/hedge funds. - Stock opened $92.30, market cap $40.19B, P/E 106.09, beta 0.98. - 12‑month low $35, high $110.15; 50‑day MA $86.73, 200‑day MA $73.18. - Dividend $0.24/share, 25% yield, ex‑dividend Dec 1, paid Dec 16. - Analyst consensus: Buy, target $102.61; UBS $102, RBC $110, R.J. $150. - Payout ratio 13.95%; current ratio 2.96, quick 2.00, debt‑to‑equity 0.15.   (gpt-oss:20b on 2025-11-10 03:44:34)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-cameco-corporation-ccj-shares-sold-by-titan-global-capital-management-usa-llc-2025-11-08/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-07</td><td>0.20</td><td>25</td><td>major dividend change</td><td>0.2 local feel              __   CCO.TO __    -> i:0.4<-                     **   ** 2025-12-16 **   <br><br>** 2025-12-16  major dividend change ***<br>FEELING: total score 0.2 --- <br> - Cameco’s institutional buying surge, higher dividend, and bullish analyst targets signal upside, but the steep P/E and recent earnings dip warrant caution. <br><br>*** REZUMAT *** - O Brien Greene increased holdings 28.8% Q2, 13,400 shares, $995k value. - Kayne Anderson raised stake 2.5% Q2, 41,410 shares, $3.074M value. - Dividend increased to $0.24/share, 25% yield, ex-div Dec 1. - Consensus buy rating, target $102.61, analysts 1 strong buy, 14 buy. - Stock opened $90.25, 50‑day MA $86.44, 200‑day MA $72.82. - 70.21% owned by hedge funds/institutions. - P/E 103.74, beta 0.98, debt‑to‑equity 0.15. - Other new positions: Atlantic $74k, Asahi $248k, Bridgewater $255k, Wellington $1.106M.   (gpt-oss:20b on 2025-11-09 03:26:40)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-cameco-corporation-ccj-shares-acquired-by-o-brien-greene-co-inc-2025-11-07/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-07</td><td>0.30</td><td></td><td>quarterly earnings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score: 0.3 --- <br> - Cameco shows strong analyst support and a 25% dividend yield, but its high P/E and recent share sell‑offs by major holders suggest caution. The stock trades above key moving averages, indicating short‑term upside, yet investors should weigh valuation and institutional activity before committing. <br><br>*** REZUMAT *** - Atria Investments cut Cameco stake by 22.3% Q2, selling 4,723 shares; remaining 16,423 shares worth $1.219M. - Manchester Capital doubled stake Q1, now 600 shares valued $25k. - Trust Co. Vermont increased stake 1,029.4% Q2, 384 shares valued $29k. - Hilltop National Bank bought new position Q2 worth $30k. - Analysts: 15 buy/strong buy, average price target $102.61; UBS set $102.00 target. - Stock price $90.25, above 50‑day SMA $86.44 and 200‑day SMA $72.82. - Dividend raised to $0.24/share, 25% yield, payout ratio 13.79%. - Market cap $39.3B, P/E 103.74, debt‑to‑equity 0.15, current ratio 2.96.   (gpt-oss:20b on 2025-11-09 02:56:09)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-atria-investments-inc-lowers-holdings-in-cameco-corporation-ccj-2025-11-07/' target='_blank'>Link</a></td></tr><tr class='neg-light'><td>2025-11-06</td><td>-0.20</td><td></td><td>large contract win</td><td>-0.2 local feel              __   CCO.TO __    -> i:0.2<-                      <br><br>FEELING: total score -0.2 --- <br> - Cameco’s shares fell 5.2% after earnings, yet strong analyst backing, a 25% dividend yield, and institutional inflows suggest upside potential; consider buying if the $150 target is credible, but monitor the high P/E and market volatility. <br><br>*** REZUMAT *** - Shares down 5.2% Thursday, low $89.42, last $90.25, volume 6.99M (+43%). - Avg rating "Buy", 1 strong buy, 14 buy, 1 hold; avg price target $102.61. - Raymond James lifted target to $150 on Oct 29. - Dividend $0.24/share, yield 25%, payout ratio 13.79%, ex‑dividend Dec 1, payment Dec 16. - Debt‑to‑equity 0.15, quick ratio 2.00, current ratio 2.96, P/E 103.74, beta 0.98. - Market cap $39.3B, 50‑day MA $86.21, 200‑day MA $72.70. - Institutional ownership 70.21%; inflows: Manchester +100%, Trust Co. Vermont +1029%, others $25‑$29k. - Analysts upgraded to "Buy" (TD, Wall Street Zen, President Capital, BMO) mid‑August/September. - 80B U.S. nuclear deal noted but impact unclear. - Top analysts favor other stocks; Cameco not in top 5 buy list.   (gpt-oss:20b on 2025-11-07 07:52:48)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-nyseccj-shares-down-52-should-you-sell-2025-11-06/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-06</td><td>0.20</td><td>25</td><td>major dividend change</td><td>0.2 local feel              __   CCO.TO __    -> i:0.4<-                     **   ** 2025-12-16 **   <br><br>** 2025-12-16  major dividend change ***<br>FEELING: total score: 0.2 --- <br> - Cameco’s 103% dividend hike and solid payout ratio signal earnings strength, while institutional inflows and a 25% yield support a long‑term hold. High P/E and sector upside from nuclear demand suggest cautious upside potential. <br><br>*** REZUMAT *** - Dividend increased to C$0.24/share, 103.4% jump, 25% yield, ex‑dividend Dec 1, payment Dec 16. - Payout ratio 7.6%, earnings $1.19/share next year, future payout 10.1%. - Stock down 1.6%, opened $95.42, 52‑wk low $35, high $110.15, market cap $41.5B. - P/E 109.67, beta 0.98, 50‑day MA $86.21, 200‑day MA $72.70. - Current ratio 2.96, quick 2.00, debt‑to‑equity 0.15. - Institutional ownership 70.21%; Envestnet +66.9%, Private Trust +315.2%, Bison +16.1%, OneDigital +13.8%. - Nuclear renaissance boosts uranium demand; analysts give Buy rating but top picks elsewhere.   (gpt-oss:20b on 2025-11-07 07:47:38)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-corporation-nyseccj-increases-dividend-to-c024-per-share-2025-11-06/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-06</td><td>0.30</td><td></td><td>quarterly earnings, dividend declaration, major contract win (US government Westinghouse reactors)</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score: +0.3 --- <br> - Cameco shows solid cash position and dividend confidence, but production delays and market uncertainty around the $80B Westinghouse deal temper upside; investors should weigh the strong financial footing against potential growth lag. <br><br>*** REZUMAT *** - Cameco Q3 2025: strong first‑9‑month results, $779M cash, $1B debt, $1B undrawn credit. - $0.24 annual dividend declared, reflecting confidence. - US $80B Westinghouse reactor purchase agreement expected to boost value. - Production forecast cut to 20 M lb uranium due to MacArthur River & Key Lake delays. - Sales volumes lower, but average realized price improved. - Uranium market remains challenging; utilities wary of long‑term contracts. - Flexibility of standby loan facilities remains strong, aiding supply adjustments. - Pricing dynamics favor established producers; potential to exceed $84/lb long‑term price. - Uncertainty over timing of US investment could impact growth.   (gpt-oss:20b on 2025-11-07 08:57:57)</td><td><a href='https://ca.finance.yahoo.com/news/cameco-corp-ccj-q3-2025-130105878.html' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-05</td><td>0.25</td><td></td><td>quarterly earnings</td><td>0.25 local feel              __   CCO.TO __    -> i:0.25<-                      <br><br>FEELING: total score 0.25 Here's a breakdown of the scoring: Analyst meetings: (Raymond James reiterates Outperform, BofA maintains Buy) - +0.05 (Low score as it's a reiteration, not a new recommendation, and targets vary) quarterly or annual results: (EPS miss, Revenue beat) - -0.15 (EPS miss is negative, revenue beat is slightly positive, but the miss is more impactful) lawsuits: (Favorable tax court decision) - +0.2 (Reduces risk, potential upside) product launches: (Curtailment operations could resume) - +0.1 (Potential for increased revenue if uranium prices rise) Backward-looking data/promotional language: -0.05 (Analyst price targets, past year trends) --- <br> - Raymond James reiterates Outperform with a $150 price target, while BofA maintains a Buy rating at $130. Despite an earnings miss, revenue exceeded expectations, and favorable tax court decision adds potential upside. <br><br>*** REZUMAT *** - Raymond James maintains Outperform rating, target price C$150. - Analyst price targets range from $78.24 to $147.72. - BofA Securities keeps Buy rating with a $130 price target. - Q2023 EPS: $0.07, missed forecast of $0.23 (69.57% surprise). - Revenue: $615 million, exceeded expectations by 8.27%. - Westinghouse Electric segment reported below-forecast EBITDA. - Favorable 2021 tax court decision reduces risk. - Curtailment operations could resume with rising uranium prices.   (gemma3:12b-it-q4_K_M on 2025-11-06 00:34:35)</td><td><a href='https://ca.investing.com/news/analyst-ratings/cameco-stock-rating-reiterated-at-outperform-by-raymond-james-93CH-4293075' target='_blank'>Link</a></td></tr><tr class='neg-light'><td>2025-11-05</td><td>-0.38</td><td></td><td>nan</td><td>-0.38 local feel              __   CCO.TO __    -> i:0.38<-                      <br><br>FEELING: total score -0.38 Reasoning: The news primarily focuses on valuation concerns, explicitly stating Cameco is "significantly overvalued" based on DCF and P/E ratios. This directly impacts the stock's perceived value and future potential. Here's a breakdown of the contributing factors: DCF analysis suggests overvaluation: -0.40 (Significant negative impact due to a clear indication of overvaluation and a fair value significantly lower than the current price.) High P/E ratio compared to industry and peers: -0.10 (Reinforces the overvaluation concern, suggesting the stock is trading at a premium.) Backward-looking data (YTD and 5-year performance): 0 (These are historical figures and have minimal impact on future stock performance.) Analyst's fair value estimates: 0 (Analysts' ratings generally receive a low score, unless there is a clear consensus across all analysts.) --- <br> - Cameco appears significantly overvalued based on both Discounted Cash Flow (DCF) and Price-to-Earnings (P/E) ratios. While the company benefits from growing interest in nuclear energy, investors should carefully consider these valuation concerns and explore alternative investment opportunities. <br><br>*** REZUMAT *** - Cameco's stock has seen a recent 8.3% drop but remains up 82.0% YTD and 1005.2% over five years. - DCF analysis suggests the stock is roughly 40.6% overvalued, with a fair value of CA$97.23 per share. - Current LTM Free Cash Flow is CA$910.6 Million, projected to reach CA$1.49 Billion by 2029. - Cameco's P/E ratio (111.52x) is much higher than industry (12.16x) and peer (13.92x) averages. - Simply Wall St's Fair Ratio for Cameco is 18.65x, highlighting significant overvaluation. - Investor Narratives offer customized fair value estimates based on individual perspectives.   (gemma3:12b-it-q4_K_M on 2025-11-06 00:33:38)</td><td><a href='https://simplywall.st/stocks/ca/energy/tsx-cco/cameco-shares/news/does-camecos-recent-8-slide-signal-a-better-entry-in-2025' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-05</td><td>0.30</td><td></td><td>Analyst meetings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score +0.3 Reasoning: The news primarily revolves around analyst upgrades and increased price targets. This falls under "analyst meetings" and generally indicates a positive sentiment. While individual analyst ratings typically receive a low score, the multiple upgrades from various institutions (BMO, President Capital, National Bankshares, Canaccord Genuity, Scotiabank, Stifel Nicolaus) suggest a developing consensus. The "outperform" and "buy" ratings further reinforce this positive outlook. The potential upside of 16% is a tangible, forward-looking metric. The slight dip in stock price today is a minor counterweight, but the overall sentiment remains bullish. The backward-looking data (50-day/200-day moving averages, P/E ratio) and past performance are given very low weight. The high P/E ratio is a potential concern, but the analyst upgrades suggest the market is anticipating future growth to justify the valuation. --- <br> - Cameco (CCO) is receiving positive attention from analysts, with multiple upgrades and increased price targets, signaling a potential upside of around 16%. While the stock experienced a slight dip today, the overall sentiment remains bullish, suggesting a favorable outlook for investors. <br><br>*** REZUMAT *** - BMO Capital Markets raised Cameco's target price to C$160.00 from C$130.00. - Potential upside of 16.28% based on the new target price. - President Capital upgraded to "buy" with a C$126.92 target (Sept 22). - National Bankshares increased target to C$140.00 with "outperform" (Oct 29). - Canaccord Genuity raised target to C$115.00 with a "buy" rating (July 30). - Scotiabank increased target to C$150.00 with "outperform" (Oct 29). - Stifel Nicolaus raised target to C$165.00 with a "buy" rating (Oct 29). - 2 analysts rate CCO as "Strong Buy" and 12 as "Buy". - Average target price is C$136.92. - Stock traded down C$4.17 to C$137.60 on Tuesday. - 50-day moving average: C$118.66, 200-day: C$99.67. - Market cap: C$59.91 billion, P/E ratio: 112.79.   (gemma3:12b-it-q4_K_M on 2025-11-06 00:32:50)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-given-new-c16000-price-target-at-bmo-capital-markets-2025-11-04/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-04</td><td>0.25</td><td></td><td>Analyst meetings</td><td>0.25 local feel              __   CCO.TO __    -> i:0.25<-                      <br><br>FEELING: total score 0.25 Rationale: Institutional activity (mixed): While some institutions reduced their stake (Envestnet), several others increased theirs significantly (Bison Wealth, Wealth Enhancement, Davenport & Co, Private Trust Co, OneDigital). This creates a slightly positive signal, but the mixed nature limits the impact. (+0.1) Analyst ratings ("Buy" consensus, target price increase): The "Buy" consensus and target price increase from Raymond James are positive signals, suggesting a bullish outlook. (+0.2) Financial ratios (quick ratio, current ratio, debt-to-equity ratio): The strong quick and current ratios, combined with a low debt-to-equity ratio, indicate financial health and stability. (+0.05) Backward-looking data and promotional language: The news includes information about past institutional activity (Q1, Q2, Q4), which receives a low score. The mention of the stock opening price and market cap is also considered promotional and receives a low score. --- <br> - Cameco (CCJ) is experiencing mixed institutional activity, with Envestnet Asset Management reducing its stake while others increase theirs. Positive analyst ratings and a "Buy" consensus suggest a bullish outlook, though the high P/E ratio warrants caution. Investors should monitor institutional trends and analyst updates. <br><br>*** REZUMAT *** - Envestnet Asset Management reduced its CCJ stake by 22.3% in Q2, selling 99,712 shares. - Bison Wealth LLC increased its stake by 16.1% in Q4, acquiring 2,975 shares. - Wealth Enhancement Advisory Services lifted its stake by 30.4% in Q1, adding 1,908 shares. - DAVENPORT & Co LLC increased its stake by 50.3% in Q1, buying 5,200 shares. - Private Trust Co. NA increased stake by 315.2% during Q1, acquiring 933 shares. - OneDigital Investment Advisors lifted stake by 13.8% in Q1, buying 2,912 shares. - 70.21% of CCJ stock is owned by institutional investors and hedge funds. - BMO Capital Markets restated an outperform rating on August 6th. - Raymond James increased target price to $150.00 on October 29th. - Consensus rating is "Buy" with an average target price of $102.61. - Stock opened at $100.93 on Tuesday with a market cap of $43.94 billion. - Company has a quick ratio of 2.00, current ratio of 2.96, and debt-to-equity ratio of 0.15.   (gemma3:12b-it-q4_K_M on 2025-11-05 01:28:01)</td><td><a href='https://www.defenseworld.net/2025/11/04/envestnet-asset-management-inc-has-25-82-million-position-in-cameco-corporation-ccj.html' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-03</td><td>0.30</td><td></td><td>quarterly earnings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score +0.3 Reasoning: Here's a breakdown of the score based on the provided news and the defined events: quarterly or annual results: The news explicitly states "Recent earnings beat estimates." This contributes a significant +0.2. The slight revenue miss is a minor offset. analyst meetings: "Analysts upgraded ratings and increased price targets" contributes +0.1. institutional investor activity: Several institutional investors increasing their stakes signals positive sentiment, contributing +0.1. This indicates confidence in the company's future performance. minor negative: The revenue slightly missing expectations is a minor negative, but the overall tone is positive, so it doesn't significantly detract from the score. low score elements: The backward-looking data (e.g., "opened at $102.18") and promotional language are given very low weight. The combination of earnings beat, analyst upgrades, and institutional buying creates a net positive sentiment. --- <br> - Several institutional investors increased their stakes in Cameco (CCJ) during Q2, signaling positive sentiment. Recent earnings beat estimates, and analysts remain bullish with price target upgrades. While revenue slightly missed expectations, the overall outlook for the company appears favorable amidst the nuclear renaissance. <br><br>*** REZUMAT *** - K.J. Harrison & Partners Inc. increased holdings by 102.6%, owning 15,307 shares ($1.135M). - Hager Investment Management Services LLC owns 30,628 shares ($2.274M), up 0.4%. - Signaturefd LLC increased holdings by 2.4%, owning 8,119 shares ($603K). - Belpointe Asset Management LLC owns 21,858 shares ($1.623M), up 1.0%. - Country Club Bank owns 43,553 shares ($1.822M), up 0.5%. - Blume Capital Management Inc. owns 13,361 shares ($992K), up 2.2%. - Institutional investors own 70.21% of CCJ's stock. - CCJ opened at $102.18, with a consensus target price of $102.61. - Q3 EPS beat estimate by $0.22 at $0.51, revenue $467.72M vs $819.79M. - Analysts upgraded ratings and increased price targets, including President Capital and Royal Bank Of Canada.   (gemma3:12b-it-q4_K_M on 2025-11-03 23:18:53)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-kj-harrison-partners-inc-buys-7750-shares-of-cameco-corporation-ccj-2025-11-03/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-03</td><td>0.35</td><td></td><td>quarterly earnings</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Breakdown: Institutional Buying: +0.1 (Indicates positive sentiment and demand for the stock) Earnings Beat: +0.2 (Beating EPS estimates is a significant positive signal) Analyst Ratings: +0.05 (Numerous "Buy" and "Outperform" ratings are positive, but analyst ratings generally receive a low score unless there's a clear consensus) Revenue Growth: 0 (Year-over-year revenue growth is backward-looking data and not impactful) Stock Performance: 0 (1-year low/high is backward-looking data) Note: The missed revenue expectation is a slight negative, but the overall positive sentiment from institutional buying and earnings beat outweighs it. --- <br> - Cameco (CCJ) is experiencing increased institutional interest and positive analyst ratings, suggesting a bullish outlook. While recent revenue fell short of estimates, the company's strong uranium business and positive future earnings projections warrant investor consideration. <br><br>*** REZUMAT *** - Institutional Buying: Several firms (C2P, Trust Co. of Vermont, Hilltop National Bank, Atticus Wealth Management, Creative Financial Designs, Manchester Capital) acquired stakes in Q2. - Earnings Beat: Reported $0.51 EPS, beating estimates by $0.22 on $467.72M revenue (vs. $819.79M expected). - Revenue Growth: Year-over-year revenue up 46.7% compared to last year's $0.14 EPS. - Analyst Ratings: Numerous "Buy" and "Outperform" ratings, consensus target price of $102.61. - Market Data: Stock opened at $102.18, market cap $44.49B, P/E 117.44. - Stock Performance: 1-year low $35.00, 1-year high $110.15.   (gemma3:12b-it-q4_K_M on 2025-11-03 23:17:27)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-5252-shares-in-cameco-corporation-ccj-acquired-by-c2p-capital-advisory-group-llc-dba-prosperity-capital-advisors-2025-11-03/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-03</td><td>0.30</td><td></td><td>quarterly earnings</td><td>0.30 GPT4 / 0.45 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: 0.3 --- <br> - Cameco (CCJ) is experiencing significant buying pressure from institutional investors, alongside positive analyst ratings and price target increases. While revenue fell short of estimates, the company's strong EPS and overall positive outlook suggest a potential buying opportunity for investors. <br><br>*** REZUMAT *** - Oppenheimer Asset Management bought 3,598 shares of CCJ in Q2, valued at $267,000. - Bison Wealth LLC increased holdings by 16.1% (21,448 shares, $1,102,000) in Q4. - Wealth Enhancement Advisory Services grew holdings by 30.4% (8,183 shares, $337,000) in Q1. - Davenport & Co LLC increased holdings by 50.3% (15,531 shares, $639,000) in Q1. - Private Trust Co. NA grew holdings by 315.2% (1,229 shares, $51,000) in Q1. - OneDigital Investment Advisors grew holdings by 13.8% (23,953 shares, $986,000) in Q1. - 70.21% of CCJ stock is held by institutional investors. - CCJ opened at $102.18, 50-day avg: $84.88, 200-day avg: $71.72. - CCJ's 12-month range: $35.00 - $110.15. - CCJ reported $0.51 EPS, beating estimate of $0.29. - Revenue: $467.72 million (vs. $819.79 million estimate). - Year-over-year revenue up 46.7%. - Goldman Sachs increased price target to $109.00 (Buy). - RBC increased price target to $110.00 (Outperform). - CLSA initiated coverage with an outperform rating and $102.00 target. - Average analyst target price: $102.61.   <br> <br>-- GPT4: +0.3, Hold, Institutional buying and positive ratings boost sentiment despite revenue miss.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-11-03 22:58:14)</td><td><a href='https://www.defenseworld.net/2025/11/03/oppenheimer-asset-management-inc-buys-shares-of-3598-cameco-corporation-ccj.html' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-02</td><td>0.35</td><td></td><td>quarterly earnings</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Here's a breakdown of the scoring: Institutional Buying: (+0.2) - Significant increases in stake by multiple institutions indicate positive sentiment and potential for further price appreciation. Analyst Ratings: (+0.1) - Multiple "Buy" and "Outperform" ratings from various institutions are generally positive, although the presence of a "Hold" rating tempers the effect. Q3 Earnings: (-0.2) - Revenue falling short of expectations is a negative signal, offsetting some of the positive sentiment. Year-over-Year Growth: (+0.1) - While backward-looking, the significant revenue and EPS growth compared to last year suggests a positive trend. High P/E Ratio: (-0.05) - The high P/E ratio is a potential risk factor, suggesting the stock may be overvalued. This is a minor negative. Note: The analyst target price and stock performance details are considered informational and have minimal impact on the overall score. --- <br> - Cameco (CCJ) is experiencing increased institutional interest and positive analyst ratings, suggesting a bullish sentiment. While recent quarterly revenue fell short of expectations, the company demonstrates strong growth compared to last year and benefits from the nuclear renaissance. Investors should consider the high P/E ratio and monitor future earnings reports. <br><br>*** REZUMAT *** - Institutional Buying: Spire Wealth Management boosted stake by 209.0%, Trust Co. of Vermont by 1029.4%, Hilltop National Bank, Atticus Wealth Management, Manchester Capital Management, Dagco Inc. all initiated or increased positions. - Analyst Ratings: Wall Street Zen raised rating to "Buy," Weiss Ratings maintains "Hold," TD Securities reissued "Buy," Raymond James raised target to $150, BMO restated "Outperform." - Average Target Price: Consensus target price is $102.61, with one "Strong Buy" rating. - Stock Performance: Opened at $102.18, market cap $44.49B, P/E 117.44, beta 0.99. - Q3 Earnings: Reported $0.51 EPS (vs. $0.29 estimate), revenue $467.72M (vs. $819.79M estimate). - Year-over-Year Growth: Quarterly revenue up 46.7%, EPS up from $0.14 last year. - Analyst Prediction: Expected EPS of 1.27 for the current year.   (gemma3:12b-it-q4_K_M on 2025-11-02 20:05:09)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-spire-wealth-management-has-779000-position-in-cameco-corporation-ccj-2025-11-02/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-02</td><td>0.30</td><td></td><td>quarterly earnings</td><td>0.30 GPT4 / 0.55 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: 0.3 --- <br> - Cameco (CCJ) is experiencing significant institutional investor interest and positive analyst ratings, suggesting a bullish outlook. While recent revenue fell short of expectations, the company's strong position in the uranium market and potential for a nuclear renaissance could drive future growth. <br><br>*** REZUMAT *** - Wealthfront Advisers LLC acquired 4,588 shares of CCJ, valued at ~$341,000. - Alliancebernstein L.P. increased its stake by 39.3%, owning 14,048,244 shares (~$578M). - Canada Pension Plan Investment Board increased stake by 215.7%, holding 2,031,332 shares (~$83.6M). - Temasek Holdings Private Ltd acquired a stake worth ~$55.5M in Q1. - AGF Management Ltd. lifted its stake by 19.0%, owning 4,037,646 shares (~$166M). - 70.21% of CCJ stock is held by institutional investors. - Multiple analysts upgraded CCJ, with a consensus rating of "Buy" and a target of $102.61. - CCJ's 12-month high is $110.15, with a market cap of $44.49 billion. - Q1 revenue was $467.72 million, up 46.7% year-over-year. - The company reported $0.51 EPS, beating estimates by $0.22.   <br> <br>-- GPT4: +0.3, Hold, Institutional interest and positive ratings suggest moderate bullish sentiment despite revenue miss.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-11-02 20:01:31)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-wealthfront-advisers-llc-purchases-shares-of-4588-cameco-corporation-ccj-2025-11-02/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-02</td><td>0.30</td><td></td><td>quarterly earnings</td><td>0.30 GPT4 / 0.45 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: 0.3 --- <br> - Cameco (CCJ) is experiencing increased institutional investor interest, with several firms boosting their stakes. Recent earnings beat estimates, though revenue fell short. Analyst ratings remain positive, suggesting a "Buy" sentiment. Investors should monitor revenue performance and analyst target prices. <br><br>*** REZUMAT *** - iA Global Asset Management Inc. purchased $37.85 million in CCJ shares during Q2. - Bison Wealth LLC increased stake by 16.1% ($1,102,000). - Wealth Enhancement Advisory Services LLC boosted stake by 30.4% ($337,000). - Davenport & Co LLC increased stake by 50.3% ($639,000). - Private Trust Co. NA increased stake by 315.2% ($51,000). - OneDigital Investment Advisors LLC increased stake by 13.8% ($986,000). - 70.21% of CCJ is owned by institutional investors. - CCJ traded at $102.18, with a 12-month range of $35.00 - $110.15. - Q3 EPS was $0.51, beating estimates by $0.22, revenue was $467.72 million. - Revenue increased 46.7% YoY, EPS increased from $0.14 to $0.51. - Analysts anticipate $1.27 EPS for the current year. - Several analysts upgraded or reiterated "Buy" ratings on CCJ. - Average analyst target price is $102.61.   <br> <br>-- GPT4: +0.3, Buy, Increased institutional interest and positive earnings boost sentiment despite revenue miss.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-11-02 20:06:48)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-ia-global-asset-management-inc-takes-3785-million-position-in-cameco-corporation-ccj-2025-11-02/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-02</td><td>0.30</td><td></td><td>analyst meetings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score +0.3 Reasoning: Here's a breakdown of the scoring based on the provided news and the defined events: Analyst Meetings: Several analysts (RBC, Scotiabank, Stifel Nicolaus, BMO Capital Markets, CLSA) have upgraded their ratings and increased price targets. This contributes a score of +0.1 5 = +0.5. However, the high P/E ratio is a cautionary note, reducing the overall impact. Stock Price Movement: The stock price crossing above its 200-day moving average is a bullish technical indicator, contributing +0.1. High P/E Ratio: The mention of a high P/E ratio (117.49) introduces a negative element, suggesting potential overvaluation. This reduces the positive sentiment slightly, subtracting -0.1. Backward-Looking Data/Promotional Language: The news includes some backward-looking data (past year trends) and promotional language, which receive a very low absolute score value. This is accounted for by reducing the overall score by a small amount. Final Calculation: +0.5 (Analyst Upgrades) + 0.1 (Stock Price Movement) - 0.1 (High P/E) - 0.05 (Backward-Looking Data) = +0.3 --- <br> - Cameco's stock price has crossed above its 200-day moving average, accompanied by several positive analyst upgrades and price target increases. This suggests a bullish sentiment, but investors should consider the high P/E ratio and broader market conditions before investing. <br><br>*** REZUMAT *** - CCO stock crossed above its 200-day moving average at C$98.49, reaching a high of C$148.95. - Current share price: C$143.34, with a volume of 1,194,627 shares traded. - RBC raised price target from C$110.00 to C$160.00. - Scotiabank increased target to C$150.00 with an "outperform" rating. - Stifel Nicolaus raised target to C$165.00 with a "buy" rating. - BMO Capital Markets increased target to C$120.00 on August 29th. - CLSA upgraded to "moderate buy" on September 9th. - 14 analysts rate CCO as Buy (2 Strong Buy). - Consensus target price: C$133.84. - Debt-to-equity ratio: 20.35. - Quick ratio: 3.74. - Market cap: C$62.41 billion. - P/E ratio: 117.49.   (gemma3:12b-it-q4_K_M on 2025-11-02 20:08:17)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-stock-crosses-above-two-hundred-day-moving-average-heres-what-happened-2025-11-01/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-01</td><td>0.35</td><td></td><td>quarterly earnings</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Here's a breakdown of the scoring: quarterly or annual results: EPS beat expectations (+0.2). Revenue miss (-0.1). The net effect is slightly positive. analyst meetings: Multiple analysts reiterated "outperform" or "buy" ratings (+0.1). buyback programs: No mention, score 0. institutional investment: Increased institutional investment (+0.1). This indicates confidence and demand. year-over-year growth: Year-over-year revenue up 46.7% (+0.1). This is a positive indicator of growth. analyst target price: Average target price: $94.71 (+0.05). This is a slight positive. The news contains some backward-looking data (past year trends) and promotional language, which would normally reduce the score, but the overall sentiment is positive due to the institutional investment and analyst ratings. --- <br> - Cameco is experiencing increased institutional investment and positive analyst ratings, suggesting growing confidence in the company's future. While revenue slightly missed estimates, the company beat EPS expectations and demonstrates strong year-over-year growth. Investors should consider the positive momentum but monitor future earnings reports. <br><br>*** REZUMAT *** - Transcend Capital Advisors purchased 2,703 shares ($201,000) in Q2. - Trust Co. of Vermont increased stake by 1,029.4% (350 shares, $29,000). - Hilltop National Bank acquired a stake worth ~$30,000 in Q2. - Atticus Wealth Management LLC acquired a stake worth ~$34,000 in Q2. - Manchester Capital Management LLC increased stake by 100% (300 shares, $25,000). - Dagco Inc. acquired a stake worth ~$28,000 in Q1. - 70.21% of stock owned by institutional investors. - CCJ shares opened at $102.18 on Friday. - 50-day moving average: $84.88; 200-day: $71.30. - Market cap: $44.49 billion; PE ratio: 117.44. - Q3 EPS: $0.51 (beat estimate by $0.22); Revenue: $467.72 million (missed estimate). - Year-over-year revenue up 46.7%. - Analysts forecast 1.27 EPS for the current year. - Multiple analysts reiterated "outperform" or "buy" ratings. - Average target price: $94.71.   (gemma3:12b-it-q4_K_M on 2025-11-01 23:32:23)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-transcend-capital-advisors-llc-purchases-new-shares-in-cameco-corporation-ccj-2025-11-01/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-01</td><td>0.30</td><td></td><td>quarterly earnings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score +0.3 Reasoning: The news primarily revolves around analyst upgrades and price target increases ("Buy" rating, "outperform" ratings, boosted price objectives). This falls under the category of analyst meetings, which typically receive a low score. However, the consistent upgrades from multiple institutions (Stifel Canada, Raymond James, Royal Bank of Canada, President Capital, Stifel Nicolaus, BMO Capital Markets) suggest a developing consensus, warranting a slightly higher score. The EPS estimates for 2026 and 2028 are forward-looking and positive, contributing to the overall positive sentiment. The high P/E ratio is noted, which tempers the positive sentiment slightly. The backward-looking data (50-day/200-day moving averages, market cap, past year trends) receives a very low score and is not factored significantly into the overall assessment. --- <br> - Cameco is receiving positive attention from analysts, with multiple upgrades and price target increases. While the current P/E ratio is high, the "Buy" rating and rising price targets suggest a positive outlook for investors willing to accept the valuation. <br><br>*** REZUMAT *** - Stifel Canada estimates Q1 2026 earnings at $0.29 EPS. - Q2 2026 EPS estimated at $0.31, Q3 at $0.34, Q4 at $0.30, FY2028 at $3.15. - Raymond James upped price target to C$150.00 with "outperform" rating. - Royal Bank of Canada increased price target to C$110.00 with "outperform" rating. - President Capital raised rating to "buy" with C$126.92 target. - Stifel Nicolaus boosted price objective to C$165.00 with "buy" rating. - BMO Capital Markets lifted target price to C$120.00. - Average analyst rating is "Buy" with a C$129.99 target. - Stock opened at C$146.49 on Friday. - 50-day moving average: C$117.11, 200-day: C$97.89. - Market cap: C$63.78 billion, P/E: 120.07.   (gemma3:12b-it-q4_K_M on 2025-11-01 23:30:43)</td><td><a href='https://www.marketbeat.com/instant-alerts/what-is-stifel-canadas-estimate-for-cameco-q1-earnings-2025-10-31/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-11-01</td><td>0.30</td><td></td><td>Analyst meetings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score +0.3 Reasoning: The news primarily revolves around analyst upgrades and price target increases. This falls under "analyst meetings" and indicates positive sentiment regarding the company's future prospects. While a consensus upgrade is not explicitly stated, the repeated mentions of "Buy" or "Strong Buy" ratings from multiple institutions suggest a generally positive outlook. The high P/E ratio is a cautionary note, but the core message is positive. The backward-looking data (12-month high/low, past year trends) receives a very low score and is not factored heavily into the overall assessment. --- <br> - Cameco (CCO) is receiving significant positive attention from analysts, with multiple price target increases and "Buy" ratings. This suggests strong confidence in the company's future prospects. Investors should consider this positive momentum, but also be aware of the high P/E ratio. <br><br>*** REZUMAT *** - RBC raised Cameco's (CCO) price target to C$160.00 from C$110.00. - Bank of America increased target to C$175.00 with a "buy" rating. - Raymond James raised target to C$150.00 with an "outperform" rating. - Scotiabank increased target to C$150.00 with an "outperform" rating. - BMO raised target to C$120.00 on August 19th. - TD Securities upped target to C$142.00 on October 21st. - 14 analysts rate CCO as "Buy" or "Strong Buy". - Average price target is C$133.84. - Stock traded down C$2.60 to C$143.89 on Friday. - 12-month low: C$49.75, 12-month high: C$153.59. - Market cap: C$62.65 billion. - P/E ratio: 117.94.   (gemma3:12b-it-q4_K_M on 2025-11-01 23:28:39)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-price-target-raised-to-c16000-at-royal-bank-of-canada-2025-10-31/' target='_blank'>Link</a></td></tr><tr class='pos-mid'><td>2025-11-01</td><td>0.50</td><td></td><td>Strategic partnership/joint venture</td><td>0.50 GPT4 / 0.40 local feel              __   CCO.TO __    -> i:0.5<-                      <br><br>FEELING: 0.5 --- <br> - Cameco's stock surged 16.2% following a significant US$80 billion government-backed partnership to accelerate Westinghouse nuclear projects. While this is a positive catalyst, investors should monitor the pace of project finalization and production bottlenecks to assess long-term growth potential. <br><br>*** REZUMAT *** - Cameco (CCO) stock up 16.2% on US$80B government partnership. - Partnership with Brookfield & U.S. Dept. of Commerce for Westinghouse reactors. - U.S. government to take 20% interest in cash distributions above US$17.5B. - Focus on nuclear power for AI data center energy needs in the U.S. - Anticipates CA$3.9B revenue and CA$1.2B earnings by 2028. - Fair value estimates range from CA$75.41 to CA$124.81 per share. - Utility contracting pace remains a key near-term catalyst. - Slovenske elektrarne agreement supports future revenue. - Potential 13% downside to current price exists.   <br> <br>-- GPT4: +0.5, Hold, Positive partnership boosts growth potential; monitor execution risks.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-11-01 23:26:59)</td><td><a href='https://simplywall.st/stocks/ca/energy/tsx-cco/cameco-shares/news/cameco-tsxcco-is-up-162-after-landmark-us80b-us-government-b' target='_blank'>Link</a></td></tr><tr class='pos-mid'><td>2025-11-01</td><td>0.60</td><td></td><td>Strategic partnership/joint venture</td><td>0.60 GPT4 / 0.40 local feel              __   CCO.TO __    -> i:0.6<-                     **   ** 2025-10-28 **   <br><br>** 2025-10-28  Strategic partnership/joint venture ***<br>FEELING: 0.6 --- <br> - Cameco's partnership with Brookfield and the US Government, backed by an $80 billion investment, signals strong growth potential in the nuclear sector. While valuation concerns exist, the positive analyst sentiment and technical indicators suggest a favorable outlook for investors. <br><br>*** REZUMAT *** - Cameco & Brookfield partner with US Government. - Agreement focuses on accelerating Westinghouse nuclear reactor deployment. - Investment of at least $80 billion is planned. - Aims to boost Westinghouse's market position in the US. - Analyst rating: Buy, C$160.00 price target. - TipRanks AI Analyst rates CCO as Outperform. - Current Market Cap: C$63.78B. - Average Trading Volume: 1,316,766.   <br> <br>-- GPT4: +0.6, Buy, Strong partnership and investment boost growth potential.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-11-01 23:25:23)</td><td><a href='https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/35846728/cameco-and-brookfield-forge-strategic-partnership-with-us-government-for-nuclear-expansion/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-31</td><td>0.35</td><td></td><td>quarterly earnings</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Here's a breakdown of the scoring: quarterly or annual results: Revenue fell short of estimates (-0.2), but EPS beat estimates by $0.22 (+0.2). The net effect is close to neutral, but the miss is slightly more impactful. analyst meetings: Several analysts reissued "outperform" ratings and a $102 target price (+0.1). Average rating is "Buy" with a $94.71 target (+0.1). institutional interest: Increased stakes by several firms (+0.2). This indicates positive sentiment and potential buying pressure. buyback programs: No mention, score 0. guidance updates: Analysts predict $1.27 EPS for the year (+0.1). This is a positive outlook. large contract wins or losses: No mention, score 0. product launches: No mention, score 0. stock splits/consolidations: No mention, score 0. backward-looking data: YoY revenue up 46.7% (low score). 12-month low/high (low score). 50/200-day MA (low score). The positive factors (institutional buying, analyst ratings, EPS beat, revenue growth outlook) outweigh the negative (revenue miss). --- <br> - Cameco (CCJ) is experiencing increased institutional interest, with several firms boosting their stakes. While the latest quarterly revenue fell short of estimates, the company demonstrates strong year-over-year growth and positive analyst ratings, suggesting a potential buying opportunity for investors. <br><br>*** REZUMAT *** - Jennison Associates LLC bought 8,285 shares, owning 0.14% ($45.74M) of CCJ. - Trust Co. of Vermont increased stake by 1,029.4%, owning 384 shares ($29,000). - Hilltop National Bank and Atticus Wealth Management LLC purchased new stakes ($30K, $34K). - Manchester Capital Management LLC boosted stake by 100% ($25,000). - Dagco Inc. purchased a new position in Cameco ($28,000). - Institutional investors own 70.21% of CCJ's stock. - CCJ stock traded down 1.8%, 50-day MA: $84.33, 200-day MA: $70.87. - 12-month low: $35.00, 12-month high: $110.15, Market Cap: $45.60B. - Q3 EPS: $0.51 (beat estimate by $0.22), Revenue: $467.72M (vs. $819.79M est.). - YoY revenue up 46.7%, analysts predict $1.27 EPS for the year. - Several analysts reissued "outperform" ratings, with a $102 target price. - Average analyst rating: "Buy", average price target: $94.71.   (gemma3:12b-it-q4_K_M on 2025-10-31 20:54:51)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-jennison-associates-llc-buys-8285-shares-of-cameco-corporation-ccj-2025-10-31/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-31</td><td>0.20</td><td>222</td><td>quarterly earnings</td><td>0.2 local feel              __   CCO.TO __    -> i:0.4<-                     **   ** 2026-07-01 **   <br><br>** 2026-07-01  quarterly earnings ***<br>FEELING: total score +0.2 Reasoning: The news primarily revolves around analyst upgrades and increased target prices. This indicates growing confidence in the company's future performance, which is a positive signal. Here's a breakdown of the contributing factors: Analyst meetings: Multiple upgrades from Raymond James Financial, Stifel Nicolaus, and National Bankshares (+0.1 x 3 = +0.3). Target price increases: The increases in target prices suggest analysts anticipate higher future stock values (+0.1). "Buy" ratings: The "Buy" ratings reinforce the positive outlook (+0.1). The average target price and opening price are less impactful as they represent a snapshot in time and don't necessarily reflect new information. The historical high/low is backward-looking and thus receives a very low score. --- <br> - Cameco (CCO) is receiving positive attention from analysts, with multiple upgrades and increased target prices. The revised earnings forecasts and "Buy" ratings suggest growing confidence in the company's performance, particularly driven by the uranium market. Investors should consider this positive momentum. <br><br>*** REZUMAT *** - Raymond James Financial raised Q3 2026 EPS estimate to $0.65 from $0.64. - Target price increased to C$150.00 by Raymond James Financial. - Stifel Nicolaus raised target price to C$165.00 with a "buy" rating. - National Bankshares raised target price to C$140.00 with an "outperform" rating. - Average analyst target price is C$129.99. - CCO opened at C$148.80 on Thursday. - Market cap is C$64.79 billion. - 12-month low is C$49.75 and high is C$153.59.   (gemma3:12b-it-q4_K_M on 2025-10-31 21:00:53)</td><td><a href='https://www.marketbeat.com/instant-alerts/analysts-issue-forecasts-for-camecos-q3-earnings-tsecco-2025-10-30/' target='_blank'>Link</a></td></tr><tr class='pos-mid'><td>2025-10-31</td><td>0.70</td><td></td><td>Strategic partnerships or joint ventures</td><td>0.70 GPT4 / 0.40 local feel              __   CCO.TO __    -> i:0.7<-                     **   ** 2025-10-28 **   <br><br>** 2025-10-28  Strategic partnerships or joint ventures ***<br>FEELING: 0.7 --- <br> - Cameco's partnership with Brookfield and the US Government, backed by an $80 billion investment, signals strong growth potential in the nuclear sector. While valuation concerns exist, the positive analyst sentiment and technical indicators suggest a favorable outlook for investors. <br><br>*** REZUMAT *** - Cameco & Brookfield partner with US Government. - Agreement focuses on accelerating Westinghouse nuclear reactor deployment. - Investment of at least $80 billion is planned. - Aims to boost Westinghouse's market position in the US. - Analyst rating: Buy, with a C$160.00 price target. - TipRanks AI rates Cameco as Outperform. - Current market cap: C$63.78 billion. - Average trading volume: 1,316,766.   <br> <br>-- GPT4: +0.7, Buy, Partnership boosts nuclear growth potential.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-10-31 20:59:15)</td><td><a href='https://www.tipranks.com/news/company-announcements/cameco-and-brookfield-forge-strategic-partnership-with-us-government-for-nuclear-expansion' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-31</td><td>0.30</td><td></td><td>quarterly earnings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Reasoning: The news primarily revolves around analyst ratings and price target revisions. While Stifel Canada lowered Q3 2025 earnings estimates, the overall sentiment is positive due to numerous analysts maintaining "Buy" or "Strong Buy" ratings and increasing price targets. This suggests continued confidence in the company's long-term prospects. Here's a breakdown of the contributing factors: Analyst meetings: Multiple analysts (CLSA, Scotiabank, Royal Bank of Canada, Desjardins, BMO Capital Markets) have raised price targets and maintained or upgraded their ratings. This contributes a score of +0.2. Forward-looking earnings estimates: The inclusion of FY2025, FY2026, FY2027, and FY2029 earnings estimates indicates a forward-looking perspective, contributing +0.1. Stifel Canada's lowered estimate: This slightly negative revision is a minor factor, reducing the overall score by -0.1. The consensus price target is also a positive signal, reinforcing the analysts' confidence. --- <br> - Despite a slight downward revision to Q3 2025 earnings estimates from Stifel Canada, Cameco maintains a "Buy" rating and a strong consensus price target. Positive ratings and price target increases from other analysts suggest continued confidence in the company's long-term prospects, particularly given its position as a leading uranium producer. <br><br>*** REZUMAT *** - Stifel Canada lowered Q3 2025 earnings estimate for Cameco to $0.24 per share. - Cameco's FY2025 earnings are now estimated at $1.49 EPS, FY2026 at $1.25 EPS, FY2027 at $2.34 EPS, FY2029 at $3.47 EPS. - CLSA rates CCO as "moderate buy" (September 2023). - Scotiabank raised price target to C$150.00 with "outperform" rating. - Royal Bank of Canada increased price target to C$110.00 with "outperform" rating. - Desjardins boosted target price to C$110.00 with a "buy" rating. - BMO Capital Markets raised target price to C$120.00. - 14 analysts rate CCO as "Buy" or "Strong Buy". - Consensus price target is C$129.99. - CCO opened at C$148.80 on Thursday. - 52-week range: C$49.75 - C$153.59. - Market capitalization: C$64.79 billion.   (gemma3:12b-it-q4_K_M on 2025-10-31 20:57:39)</td><td><a href='https://www.marketbeat.com/instant-alerts/stifel-canada-issues-negative-estimate-for-cameco-earnings-2025-10-30/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-30</td><td>0.30</td><td></td><td>analyst meetings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score +0.3 Reasoning: The news primarily revolves around analyst upgrades and a significant stock price increase. This falls under "analyst meetings" (+0.1) and a general positive sentiment suggesting "strong future potential." The multiple target price increases from various institutions are a significant positive signal. The high P/E ratio is a cautionary note, but doesn's negate the positive momentum. The increased trading volume also supports the positive sentiment. The quick ratio and debt-to-equity ratio are neutral. The backward-looking data (past year trends) and the high P/E ratio are given low weight. --- <br> - Cameco (CCO) experienced a significant 22.9% surge, driven by multiple analyst upgrades and increased trading volume. Positive sentiment and revised price targets suggest strong future potential, though the high P/E ratio warrants caution. Investors should monitor uranium market dynamics. <br><br>*** REZUMAT *** - CCO stock price jumped 22.9% on Wednesday, trading as high as C$153.59. - Trading volume increased 155%, reaching 3,181,171 shares. - National Bankshares raised target price to C$115.00 with "outperform" rating (Aug 22). - Raymond James Financial upped target to C$120.00 (Aug 21). - President Capital upgraded to "buy" with C$126.92 target (Sept 22). - Stifel Nicolaus raised target to C$150.00 (Oct 15). - BMO Capital Markets upped target to C$120.00 (Aug 29). - Average analyst rating is "Buy" with a C$119.61 target. - Company has a quick ratio of 3.74 and debt-to-equity ratio of 20.35. - Market cap is C$64.86 billion with a PE ratio of 122.11.   (gemma3:12b-it-q4_K_M on 2025-10-30 20:20:47)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-trading-229-higher-heres-why-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-30</td><td>0.30</td><td></td><td>Analyst meetings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score +0.3 Reasoning: The news primarily revolves around analyst upgrades and price target increases, which indicates a positive outlook for the stock. This falls under "analyst meetings" and warrants a positive score. While the average price target is slightly below the current trading price, the overwhelming consensus of "buy" or "strong buy" ratings and the recent price increase suggest a bullish sentiment. The score is not higher due to the mention of a "slight potential downside" based on one target, which tempers the overall positivity. The trading volume and market cap are irrelevant to the financial outlook. --- <br> - Cameco (CCO) is receiving significant positive attention from analysts, with multiple price target increases and "buy" ratings. While a slight potential downside exists based on one target, the overall sentiment is bullish, suggesting a potential for stock price appreciation. Investors should consider this positive momentum. <br><br>*** REZUMAT *** - Scotiabank raised Cameco's price target from C$130.00 to C$150.00 with an "outperform" rating. - Bank of America increased target to C$175.00 with a "buy" rating. - Canaccord Genuity raised target to C$115.00 with a "buy" rating on July 30th. - National Bankshares increased target to C$140.00 with an "outperform" rating. - CLSA upgraded to "moderate buy" on September 9th. - TD Securities upped target to C$142.00 on October 21st. - 14 analysts rate CCO as "Buy" or "Strong Buy". - Average price target is C$129.99. - Stock traded up C$2.02 to C$151.00 on Wednesday. - Trading volume was 890,881 shares. - Market cap is C$65.74 billion.   (gemma3:12b-it-q4_K_M on 2025-10-30 20:06:56)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-stock-price-expected-to-rise-scotiabank-analyst-says-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-30</td><td>0.20</td><td></td><td>nan</td><td>0.2 local feel              __   CCO.TO __    -> i:0.2<-                      <br><br>FEELING: total score +0.2 Reasoning: The news primarily revolves around analyst price target increases and upgrades. While these are positive signals, they don't represent a concrete financial event like a merger or earnings surprise. Analyst actions are generally given a low score unless there's a clear consensus. The fact that multiple analysts have raised targets suggests a slightly more bullish sentiment, justifying a small positive score. The 52-week high and low are backward-looking data and receive a very low score. The "moderate buy" rating is also a relatively mild endorsement. --- <br> - Cameco (CCO) is experiencing significant positive sentiment with multiple analysts raising price targets, indicating strong potential. While a slight potential downside is noted, the overall trend suggests a bullish outlook for investors. <br><br>*** REZUMAT *** - Raymond James Financial raised Cameco's price target to C$150.00 from C$130.00. - CLSA upgraded Cameco to "moderate buy" on September 9th. - Stifel Nicolaus increased price target to C$150.00 on October 21st. - Bank of America increased price target to C$130.00 on August 19th. - TD Securities increased price target to C$142.00 on October 21st. - Desjardins increased price target to C$110.00 with a "buy" rating on August 1st. - CCO traded up C$2.02 to reach C$151.00 on Wednesday. - The stock has a 52-week low of C$49.75 and a 52-week high of C$153.59. - MarketBeat reports a consensus rating of "Buy" with an average price target of C$129.99.   (gemma3:12b-it-q4_K_M on 2025-10-30 20:12:41)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-price-target-raised-to-c15000-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-30</td><td>0.30</td><td></td><td>analyst meetings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Reasoning: Analyst meetings: Multiple upgrades and increased price targets from various analysts (Canaccord Genuity, BMO Capital Markets, National Bankshares, CLSA, President Capital) contribute a positive score of +0.15 (0.03 per upgrade). Stock Price Surge: The 22.9% price surge itself indicates positive market sentiment, adding +0.1. Increased Trading Volume: A 155% increase in trading volume suggests increased investor interest and momentum, contributing +0.05. High P/E Ratio: The high P/E ratio (122.11) introduces a note of caution, slightly reducing the overall score (-0.05). This suggests the market has high expectations for future growth, which could be a risk. The news primarily revolves around analyst sentiment and recent stock performance, which are considered positive indicators. The high P/E ratio acts as a minor counterweight. --- <br> - Cameco (CCO) experienced a significant 22.9% price surge, fueled by positive analyst ratings and increased trading volume. The stock's strong buy and buy ratings, along with rising price targets, suggest continued positive momentum, though the high P/E ratio warrants caution. <br><br>*** REZUMAT *** - CCO stock price rose 22.9% to C$148.98 on Wednesday. - Trading volume increased 155% to 3,181,171 shares. - Analyst Canaccord Genuity increased price target to C$115.00 on July 30th. - BMO Capital Markets raised target to C$120.00 on August 29th. - National Bankshares increased target to C$115.00 on August 22nd. - CLSA upgraded to "moderate buy" on September 9th. - President Capital upgraded to "buy" with C$126.92 target on September 22nd. - Consensus rating is "Buy" with a target price of C$119.61. - Company has a market cap of C$64.86 billion and a P/E ratio of 122.11.   (gemma3:12b-it-q4_K_M on 2025-10-30 20:08:41)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-stock-price-up-229-whats-next-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-30</td><td>0.30</td><td></td><td>Analyst meetings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Breakdown: Analyst meetings: Multiple analysts raised price targets and ratings ("Buy" or "Strong Buy"). This contributes a positive score of +0.1. The fact that there's a consensus across analysts strengthens this. Stock Price Surge: The 22.9% price surge itself is a significant event, indicating strong investor sentiment. This contributes +0.2. High PE Ratio: The high PE ratio (122.11) is a potential negative, but it's not explicitly detrimental to the company's future prospects. It's more of a valuation consideration. Backward-looking data: The 50-day and 200-day moving averages, and the average target price are backward-looking data and receive a very low score. Market Dynamics: The mention of "monitor uranium market dynamics" suggests a potential risk factor, but it's not a direct negative in the news itself. The overall sentiment is positive due to the analyst upgrades and price surge, but the high PE ratio and need to monitor market dynamics temper the enthusiasm slightly. --- <br> - Cameco (CCO) experienced a significant price surge (22.9%) driven by positive analyst ratings and increased trading volume. While the PE ratio is high, the "Buy" consensus and rising price targets suggest continued investor confidence. Consider a position, but monitor uranium market dynamics. <br><br>*** REZUMAT *** - CCO stock rose 22.9% on Wednesday, trading as high as C$153.59. - Trading volume increased 155% to 3,181,171 shares. - Scotiabank raised price target to C$130.00 with "outperform" rating (Oct 14). - BMO Capital Markets boosted target to C$120.00 (Aug 29). - Stifel Nicolaus raised target to C$150.00 (Oct 21). - 12 analysts rate CCO as "Buy" or "Strong Buy". - Average target price is C$119.61. - 50-day moving average: C$115.14; 200-day: C$96.91. - Market cap: C$64.86 billion; PE ratio: 122.11.   (gemma3:12b-it-q4_K_M on 2025-10-30 20:19:25)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-trading-229-higher-still-a-buy-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-30</td><td>0.30</td><td></td><td>nan</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score +0.3 Reasoning: The news primarily revolves around analyst upgrades and price target increases, which indicates strong confidence in the company's future prospects. This aligns with the "analyst meetings" event, specifically upgrades from major institutions (+0.1). The significant price target increases (Stifel Nicolaus raised target to C$165.00 from C$150.00, representing a 9.27% upside) further reinforces this positive sentiment, pushing the score slightly higher. The upward movement in the stock price (+C$2.02) is a consequence of this positive news. While the relatively high P/E ratio is mentioned, it's presented as a cautionary note rather than a negative factor. The backward-looking data (12-month high/low) and market capitalization are given very low weight. --- <br> - Cameco (CCO) is receiving significant positive attention from analysts, with multiple price target increases and "buy" ratings. This suggests strong confidence in the company's future prospects, potentially driven by the uranium market. Investors should consider this positive momentum, but also acknowledge the relatively high P/E ratio. <br><br>*** REZUMAT *** - Stifel Nicolaus raised Cameco's price target to C$165.00 from C$150.00, indicating 9.27% upside. - President Capital upgraded Cameco to "buy" with a C$126.92 price target (September 22nd). - Scotiabank raised target from C$130.00 to C$150.00, rating "outperform". - Desjardins increased target to C$110.00 with a "buy" rating (August 1st). - Bank of America raised target to C$175.00 with a "buy" rating. - CLSA upgraded to "moderate buy" (September 9th). - Average analyst rating is "Buy" with a consensus price target of C$129.99. - CCO stock traded up C$2.02 to C$151.00 on Wednesday. - 12-month high: C$153.59, 12-month low: C$49.75. - Market capitalization: C$65.74 billion.   (gemma3:12b-it-q4_K_M on 2025-10-30 20:11:04)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-price-target-raised-to-c16500-at-stifel-nicolaus-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-30</td><td>0.20</td><td></td><td>Analyst meetings</td><td>0.2 local feel              __   CCO.TO __    -> i:0.2<-                      <br><br>FEELING: total score 0.2 Reasoning: The news primarily revolves around analyst ratings and price target revisions ("Buy" consensus, CLSA raised rating, TD Securities upped price target, National Bankshares boosted target, Stifel Nicolaus raised target, President Capital upgraded). This triggers a positive sentiment, but the impact is moderate. Analyst upgrades generally receive a low score unless there's a clear consensus, which is partially present here. The high P/E ratio is a cautionary note, slightly tempering the positive sentiment. The increased trading volume also suggests investor interest and potential upward momentum. The backward-looking data (past year trends, market cap, beta) receives a very low score. --- <br> - Cameco (CCO) experienced a significant 22.9% jump, fueled by positive analyst ratings and increased trading volume. Investors should note the revised price targets and "Buy" consensus, but also consider the high P/E ratio. <br><br>*** REZUMAT *** - CCO stock price surged 22.9% on Wednesday, closing at C$148.98. - Trading volume increased 155% to approximately 3,181,171 shares. - CLSA raised rating to "moderate buy" on September 9th. - TD Securities upped price target to C$142.00 on October 21st. - National Bankshares boosted target to C$115.00 with "outperform" on August 22nd. - Stifel Nicolaus raised target to C$150.00 on October 21st. - President Capital upgraded to "buy" with C$126.92 target on September 22nd. - 12 analysts rate CCO as "Buy" with an average target of C$119.61. - Market cap is C$64.86 billion, P/E is 122.11, and beta is 1.12.   (gemma3:12b-it-q4_K_M on 2025-10-30 20:11:49)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-stock-price-up-229-heres-why-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-30</td><td>0.30</td><td></td><td>analyst meetings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score +0.3 Reasoning: The news primarily revolves around positive analyst revisions and a "Buy" consensus rating, which directly impacts investor sentiment and stock value. This falls under the category of analyst meetings (+0.1). The significant price surge (22.9%) and increased trading volume further reinforce the positive sentiment. While the high P/E ratio is mentioned as a consideration, it doesn't negate the overall positive momentum. The price target increases from multiple institutions are a strong indicator of future expectations. The backward-looking data (50-day/200-day moving averages, market cap, ratios) receives a very low score. --- <br> - Cameco (CCO) experienced a significant price surge (22.9%) driven by positive analyst revisions and increased trading volume. With a "Buy" consensus rating and rising price targets, the stock appears attractive, though the high P/E ratio warrants consideration. <br><br>*** REZUMAT *** - CCO stock price rose 22.9% to C$148.98 on Wednesday. - Trading volume increased 155% to 3,181,171 shares. - Desjardins raised price target to C$110.00 on August 21st. - Stifel Nicolaus raised price target to C$150.00 on October 21st. - Canaccord Genuity raised price target to C$115.00 on July 30th. - BMO Capital Markets raised price target to C$120.00 on August 29th. - Bank of America raised price target to C$130.00 on August 29th. - 12 analysts rate CCO as "Buy" or "Strong Buy". - Consensus price target is C$119.61. - 50-day moving average: C$115.14, 200-day: C$96.91. - Market capitalization: C$64.86 billion. - Quick ratio: 3.74, Debt-to-equity ratio: 20.35.   (gemma3:12b-it-q4_K_M on 2025-10-30 20:10:08)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-stock-price-up-229-still-a-buy-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-30</td><td>0.25</td><td></td><td>nan</td><td>0.25 local feel              __   CCO.TO __    -> i:0.25<-                      <br><br>FEELING: total score +0.25 Reasoning: The news primarily revolves around analyst upgrades and increased price targets. This falls under "analyst meetings" and indicates a positive sentiment. While analyst ratings generally receive a low score, the consistent upgrades from multiple institutions (Bank of America, Stifel Nicolaus, CLSA, President Capital, Desjardins, Royal Bank of Canada) suggest a developing consensus. The potential upside of 15.89% also contributes to the positive sentiment. The stock price increase on Wednesday is a secondary positive indicator. The backward-looking data (50-day/200-day moving averages, one-year high/low) receives a very low score and is largely ignored. --- <br> - Cameco (CCO) is experiencing positive momentum with multiple analysts raising price targets, indicating a potential upside of around 15.89%. The stock's recent performance and analyst ratings suggest a favorable outlook for investors. <br><br>*** REZUMAT *** - Bank of America raised Cameco's (CCO) price target to C$175.00 from C$130.00 on Wednesday. - Analyst rating is "buy" with a potential upside of 15.89%. - Stifel Nicolaus increased target to C$150.00 on October 21st. - CLSA upgraded to "moderate buy" on September 9th. - President Capital upgraded to "buy" with a C$126.92 target on September 22nd. - Desjardins raised target to C$110.00 with a "buy" rating on August 1st. - Royal Bank of Canada raised target to C$110.00 with "outperform" on August 1st. - 14 analysts recommend the stock with a consensus rating of "Buy". - Average consensus price target is C$129.99. - CCO traded at C$151.00 on Wednesday, up C$2.02. - 50-day moving average: C$115.14; 200-day: C$96.91. - One-year low: C$49.75; one-year high: C$153.59.   (gemma3:12b-it-q4_K_M on 2025-10-30 20:13:01)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-price-target-raised-to-c17500-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-30</td><td>0.30</td><td></td><td>analyst meetings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score +0.3 Reasoning: Stock price surge (22.9%): This is a significant positive event. I'm assigning a +0.3 score. Multiple analysts raising price targets: This reinforces the positive sentiment and suggests increased confidence in the company's future performance. This adds to the positive impact of the stock price surge. Increased trading volume: This indicates strong investor interest and validates the price movement. Analyst meetings: While not a clear consensus, multiple analysts raising price targets is a positive signal. I'm giving it a low positive score. The other metrics (P/E, ratios, moving averages) are backward-looking data and receive a very low score. The recommendation to "consider a small position" is promotional language and receives a very low score. --- <br> - Cameco's stock price surged 22.9% with multiple analysts raising price targets. While the average target remains below the recent high, the positive sentiment and increased trading volume suggest continued investor interest. Consider a small position, monitoring uranium market trends. <br><br>*** REZUMAT *** - Stock price increased by 22.9% on Wednesday, October 30, 2024. - Trading volume increased 155% to 3,181,171 shares. - Previous close was C$121.26; last traded at C$148.98. - BMO, TD Securities, Bank of America, Raymond James, and CLSA raised price targets. - Average analyst target price is C$119.61. - Market cap: C$64.86 billion. - P/E ratio: 122.11, PEG ratio: 2.22, Beta: 1.12. - 50-day moving average: C$115.14, 200-day moving average: C$96.91. - Current ratio: 2.88, quick ratio: 3.74, debt-to-equity ratio: 20.35.   (gemma3:12b-it-q4_K_M on 2025-10-30 20:13:46)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-stock-price-up-229-should-you-buy-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-30</td><td>0.30</td><td></td><td>Analyst meetings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Reasoning: Analyst Meetings (Upgrades): Multiple analysts (Desjardins, TD Securities, Stifel Nicolaus) raised their price targets. This contributes a positive score of +0.1 to +0.2. The consensus "Buy" rating further reinforces this. Stock Price Surge: The 22.9% surge in stock price itself indicates positive market sentiment, adding a small +0.1. Increased Trading Volume: A 155% increase in trading volume suggests increased investor interest and momentum, contributing a minor +0.05. High P/E Ratio: The high P/E ratio (122.11) is a potential negative, but it's being outweighed by the positive analyst sentiment and price action. It doesn't warrant a significant negative score. Backward-Looking Data/Promotional Language: The news includes some backward-looking data (e.g., past year trends) and promotional language, which are given very low absolute score values. --- <br> - Cameco (CCO) experienced a significant 22.9% surge, driven by positive analyst upgrades and increased trading volume. While the stock's valuation appears high (P/E of 122.11), the positive sentiment and rising price targets suggest continued investor confidence in the uranium market. <br><br>*** REZUMAT *** - CCO stock jumped 22.9% on Wednesday, trading as high as C$153.59. - Trading volume increased 155% to 3,181,171 shares. - Desjardins raised target price to C$110.00 on August 1st. - TD Securities lifted price objective to C$142.00 on October 21st. - Stifel Nicolaus raised target to C$150.00 on October 21st. - Consensus rating is "Buy" with an average price target of C$119.61. - Company has a debt-to-equity ratio of 20.35 and market cap of C$64.86 billion.   (gemma3:12b-it-q4_K_M on 2025-10-30 20:15:09)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-trading-up-229-heres-what-happened-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-30</td><td>0.30</td><td></td><td>analyst meetings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Rationale: Analyst Meetings (Upgrades): Multiple analysts have upgraded their ratings and increased price targets. This contributes a positive score of +0.1. The consensus of "Buy" ratings from 12 analysts further reinforces this positive sentiment. Stock Price Surge: The significant price increase (22.9%) is a direct market reaction and indicates positive sentiment. This contributes a small positive score of +0.1. Positive Outlook: The news mentions a "positive outlook," which suggests future growth potential. This adds a minor positive score of +0.1. High P/E Ratio: The high P/E ratio (122.11) is a cautionary note, but it doesn't necessarily indicate a negative outlook. It suggests the stock might be richly valued, but it doesn't inherently detract from the positive sentiment driven by analyst upgrades and the company's position. Backward-Looking Data/Publicity: The news includes some backward-looking data (previous close, trading volume) and promotional language, which receive a low score. --- <br> - Cameco (CCO) has seen a significant price surge (22.9%) driven by positive analyst ratings and price target increases. While the P/E ratio is high (122.11), the company's position as a major uranium producer and positive outlook suggest potential for continued growth, but investors should consider the valuation. <br><br>*** REZUMAT *** - CCO stock price rose 22.9% to C$148.98 on Wednesday. - Trading volume increased 155% to 3,181,171 shares. - Previous close was C$121.26. - Canaccord Genuity raised target to C$115.00 (Buy). - Raymond James Financial increased target to C$120.00. - CLSA upgraded to "moderate buy" rating. - RBC raised target to C$110.00 (Outperform). - National Bankshares lifted target to C$115.00 (Outperform). - 12 analysts rate CCO as Buy or Strong Buy. - Average target price is C$119.61.   (gemma3:12b-it-q4_K_M on 2025-10-30 20:16:41)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-trading-up-229-should-you-buy-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-30</td><td>0.30</td><td></td><td>Analyst meetings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score +0.3 Reasoning: Analyst Meetings: Multiple analysts raised price targets and maintained a "Buy" consensus. This contributes a positive score of +0.1. The fact that several institutions participated strengthens this. Stock Price Surge: The 22.9% surge itself indicates positive market sentiment and buying pressure, contributing +0.2. High P/E Ratio: The mention of a high P/E ratio introduces a note of caution, which slightly reduces the overall score. However, it doesn't negate the positive momentum. Backward-Looking Data/Promotional Language: The article includes some backward-looking data (past year trends) and promotional language, which are given very low absolute score values. The overall sentiment is positive due to the analyst upgrades and significant price increase, but the high P/E ratio introduces a degree of caution. --- <br> - Cameco (CCO) experienced a significant 22.9% surge, driven by upward revisions of price targets from multiple analysts. Positive sentiment and a "Buy" consensus suggest continued potential, though the high P/E ratio warrants caution. Investors should monitor uranium market dynamics. <br><br>*** REZUMAT *** - CCO stock jumped 22.9% on Wednesday, trading as high as C$153.59. - Trading volume increased 155% to 3,181,171 shares. - Stifel Nicolaus raised price target to C$150.00 (from C$115.00). - Raymond James Financial raised target to C$120.00 (from C$115.00). - National Bankshares gave "outperform" rating, target C$115.00. - TD Securities raised target to C$142.00 (from C$118.00). - Bank of America raised target to C$130.00 (from C$110.00). - Consensus rating is "Buy" with a target price of C$119.61. - Market cap is C$64.86 billion, P/E ratio is 122.11.   (gemma3:12b-it-q4_K_M on 2025-10-30 20:18:01)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-shares-up-229-heres-why-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-29</td><td>0.30</td><td></td><td>Strategic partnerships or joint ventures</td><td>0.30 GPT4 / 0.45 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: 0.3 --- <br> - Cameco's partnership with Brookfield and the US Government, backed by an $80 billion investment, signals strong growth potential. While valuation concerns exist, the positive analyst ratings and robust cash flow suggest a favorable long-term outlook for investors. <br><br>*** REZUMAT *** - Cameco & Brookfield partner with US Government. - Agreement aims to accelerate Westinghouse reactor deployment. - Investment value is at least US$80 billion. - Partnership boosts demand for Cameco's products/services. - Analyst rating: Buy, C$129.00 price target. - TipRanks AI Analyst rates CCO as Outperform. - High P/E ratio suggests potential overvaluation. - Current market cap: C$53.72B. - Average Trading Volume: 1,315,867   <br> <br>-- GPT4: +0.3, Hold, Strong partnership and investment boost growth potential; valuation concerns moderate immediate impact.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-10-30 00:32:16)</td><td><a href='https://www.theglobeandmail.com/investing/markets/stocks/CCJ/pressreleases/35753537/cameco-and-brookfield-partner-with-us-government-to-boost-nuclear-reactor-deployment/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-29</td><td>0.30</td><td></td><td>Analyst meetings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score +0.3 Reasoning: The news primarily revolves around positive analyst ratings and target price increases. This falls under "analyst meetings" which typically receives a low score (+0.1). However, the significant nature of the target price increases and the "Buy" consensus rating elevates the score slightly. The 22% price jump itself is a consequence of this positive sentiment, reinforcing the impact. The high P/E ratio is a cautionary note, preventing a higher score. The backward-looking data (50/200-day moving averages, past year trends) and market cap/P/E ratio are given very low weight. --- <br> - Cameco (CCO) has seen a significant 22% jump in price, fueled by positive analyst ratings and target price increases. With a "Buy" consensus rating and rising price targets, the stock appears to be a positive investment opportunity, though the high P/E ratio warrants consideration. <br><br>*** REZUMAT *** - CCO stock price increased by 22% on Tuesday, October 22nd. - High trading volume: 1,831,823 shares, up 48% from the average. - Desjardins raised target price to C$110.00 on August 1st. - Scotiabank raised target price to C$130.00 on October 14th. - Stifel Nicolaus raised target price to C$150.00 on October 14th. - BMO Capital Markets raised target price to C$120.00 on August 29th. - Raymond James Financial raised target price to C$120.00 on August 21st. - Consensus rating is "Buy" with a target price of C$119.61. - 50-day moving average: C$114.21; 200-day moving average: C$96.24. - Market cap: C$64.86 billion; P/E ratio: 122.11.   (gemma3:12b-it-q4_K_M on 2025-10-30 00:30:38)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-tsecco-trading-22-higher-still-a-buy-2025-10-28/' target='_blank'>Link</a></td></tr><tr class='pos-mid'><td>2025-10-29</td><td>0.70</td><td></td><td>Large contract wins</td><td>0.70 GPT4 / 0.40 local feel              __   CCO.TO __    -> i:0.7<-                      <br><br>FEELING: 0.7 --- <br> - Cameco's stock has seen a significant jump (28.4%) following its involvement in a substantial US$80 billion nuclear deal. This signals positive momentum and potential growth for investors interested in the nuclear energy sector. <br><br>*** REZUMAT *** - Cameco (TSX:CCO) stock up 28.4%. - Involved in a US$80 billion nuclear deal. - Positive signal for nuclear energy sector.   <br> <br>-- GPT4: +0.7, Buy, Significant deal boosts growth potential.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-10-30 00:29:06)</td><td><a href='https://finance.yahoo.com/news/why-cameco-tsx-cco-28-081427383.html' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-29</td><td>0.30</td><td></td><td>Strategic partnership/joint venture</td><td>0.30 GPT4 / 0.40 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: 0.3 --- <br> - Cameco's partnership with the U.S. government and Westinghouse, backed by $80 billion, signals strong growth potential in the nuclear sector. While valuation concerns exist, the company's strategic positioning and robust cash flow suggest a positive long-term outlook for investors. <br><br>*** REZUMAT *** - Cameco partners with U.S. Government & Westinghouse in $80B nuclear initiative. - Initiative aims to build new reactors using Westinghouse technology. - Collaboration supports U.S. energy infrastructure & AI development. - Analyst rating: Buy with C$129.00 price target. - TipRanks AI Analyst rates CCO as Outperform. - High P/E ratio suggests potential overvaluation. - Company's market cap is C$53.72B. - Average trading volume: 1,315,867   <br> <br>-- GPT4: +0.3, Hold, Partnership boosts long-term growth; short-term impact limited by valuation concerns.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-10-30 00:27:42)</td><td><a href='https://www.theglobeandmail.com/investing/markets/stocks/CCJ-N/pressreleases/35753539/cameco-joins-u-s-government-and-partners-in-80-billion-nuclear-power-initiative/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-29</td><td>0.30</td><td></td><td>quarterly earnings</td><td>0.30 GPT4 / 0.45 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: 0.3 --- <br> - Cameco (CCJ) is experiencing increased institutional interest, with several firms acquiring new stakes. Positive analyst ratings and price target upgrades suggest a bullish outlook. While revenue fell short of estimates, the company's strong EPS and positive guidance indicate potential for future growth. <br><br>*** REZUMAT *** - IQ EQ FUND MANAGEMENT acquired 20,348 CCJ shares, valued at $1.51M in Q2. - Trust Co. of Vermont increased holdings by 1,029.4% in Q2, owning 384 shares. - Several firms (Hilltop, Atticus, Manchester, Dagco) acquired new or increased stakes. - 70.21% of CCJ stock is held by institutional investors. - CLSA rates CCJ as "outperform" with a $102 target. - RBC raised target price to $110 with an "outperform" rating. - Analysts average rating is "Buy" with a target price of $89.55. - CCJ opened at $106.90 with a 12-month high of $110.16. - Q2 EPS was $0.51, exceeding estimates by $0.22. - Revenue was $467.72M, below estimated $819.79M. - FY 2025 guidance set, analysts expect 1.27 EPS.   <br> <br>-- GPT4: +0.3, Hold, Institutional interest and positive ratings support growth despite revenue miss.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-10-30 00:25:50)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-iq-eq-fund-management-ireland-ltd-makes-new-investment-in-cameco-corporation-ccj-2025-10-29/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-28</td><td>0.35</td><td></td><td>Strategic partnership</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Breakdown: Major political actions like war or major strikes: (0.1) - The news highlights a renewed focus on nuclear power spurred by government investment, aligning with a vision for energy sovereignty. This implies a strategic shift and potential long-term benefits, but the impact is not overtly negative. Strategic partnerships or joint ventures: (0.3) - The partnership between Westinghouse, Cameco, Brookfield, and the U.S. government is a significant strategic move. The potential for synergy is clear, given the scale of investment and the alignment of goals. The involvement of Brookfield with its substantial investment plans adds further weight. Product launches: (0.05) - While not a direct product launch, the construction of new reactors using Westinghouse technology can be considered a significant advancement in nuclear energy infrastructure. Regulatory approvals: (0.0) - The news mentions the need for regulatory approvals, which introduces a degree of uncertainty, but it's not a negative in itself. Low-scoring elements: Backward-looking data or past trends (e.g., Westinghouse powering half the world's reactors) - minimal impact. Publicity-related articles - minimal impact. --- <br> - This is a significant development for Westinghouse, Cameco, and Brookfield, backed by substantial U.S. government investment. It signals a renewed focus on nuclear power and AI infrastructure, potentially boosting these companies' stock performance, but investors should monitor project execution and regulatory approvals. <br><br>*** REZUMAT *** - US Government, Brookfield, and Cameco partner for nuclear power expansion. - $80 billion to construct new reactors using Westinghouse technology. - Partnership aligns with President Trump's vision for energy sovereignty and AI leadership. - Brookfield has over $1 trillion invested and plans to double it in the next decade. - Cameco supplies uranium fuel, supporting Westinghouse's technology globally. - Each reactor project creates ~45,000 jobs in 43 states. - Partnership includes profit sharing for all parties, including the American people. - Westinghouse is a leader in nuclear energy, with technology powering half the world's reactors.   (gemma3:12b-it-q4_K_M on 2025-10-29 00:20:37)</td><td><a href='https://www.businesswire.com/news/home/20251027603867/en/United-States-Government-Brookfield-and-Cameco-announce-transformational-partnership-to-deliver-long-term-value-using-Westinghouse-nuclear-reactor-technology' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-28</td><td>0.35</td><td></td><td>Guidance update</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Here's a breakdown of the scoring: Institutional activity (mixed): 0.05 (While there's selling, the significant increases by multiple institutions suggest overall positive sentiment, but the mixed nature tempers the score.) Analyst ratings ("Buy" rating, $89.55 target): 0.1 (Positive, but analysts' ratings generally receive a low score unless there's a clear consensus. This is a moderate boost.) Revenue slightly missed estimates: -0.05 (Slightly negative, but tempered by the EPS beat.) Q3 EPS beat estimates: 0.15 (Positive surprise, a significant contributor to the overall score.) FY 2025 guidance: 0.1 (Forward-looking guidance is positive, indicating future expectations.) --- <br> - Cameco ($CCJ) is experiencing mixed institutional activity, with some reducing stakes while others significantly increase holdings, reflecting varied investor sentiment. Positive analyst ratings and a consensus price target of $89.55 suggest continued growth potential, though recent revenue slightly missed estimates. <br><br>*** REZUMAT *** - Sumitomo Mitsui Trust Group Inc. sold 5.7% of its CCJ shares in Q2. - Bison Wealth LLC increased holdings by 16.1%, now owning $1,102,000 worth. - Wealth Enhancement Advisory Services LLC increased holdings by 30.4%, valued at $337,000. - Cambridge Investment Research Advisors Inc. increased holdings by 4.2%, now owning $3,088,000. - Mirae Asset Global Investments Co. Ltd. increased holdings by 159%, now owning $2,496,000. - Nicholson Meyer Capital Management Inc. acquired a new $350,000 position. - 70.21% of CCJ stock is held by institutional investors. - Analysts maintain a "Buy" rating with a $89.55 consensus price target. - CCJ opened at $86.60, has a market cap of $37.70 billion. - Q3 EPS was $0.51, beating estimates by $0.22, revenue was $467.72 million. - FY 2025 guidance set, analysts expect $1.27 EPS for the current year.   (gemma3:12b-it-q4_K_M on 2025-10-29 00:18:17)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-cameco-corporation-ccj-shares-sold-by-sumitomo-mitsui-trust-group-inc-2025-10-28/' target='_blank'>Link</a></td></tr><tr class='pos-mid'><td>2025-10-28</td><td>0.70</td><td></td><td>Strategic partnerships or joint ventures</td><td>event_TBD 0.70 GPT4 / 0.40 local feel              __   CCO.TO __    -> i:0.7<-                      <br><br>FEELING: 0.7 --- <br> - Cameco and Brookfield's partnership with the U.S. government to build nuclear reactors, backed by $80 billion in investment, signals strong growth potential for Cameco and Westinghouse, reinforcing the nuclear power sector's expansion. <br><br>*** REZUMAT *** - Cameco & Brookfield partner with U.S. government for reactor construction. - U.S. government to facilitate $80 billion in Westinghouse reactor financing. - Partnership boosts confidence in nuclear power's durable growth. - U.S. government receives 20% of cash distributions over $17.5 billion. - Potential for U.S. government to acquire 20% Westinghouse IPO shares. - Agreement supports U.S. national security and infrastructure.   <br> <br>-- GPT4: +0.7, Buy, Strong partnership and investment boost nuclear sector growth potential.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-10-29 00:16:47)</td><td><a href='https://www.marketscreener.com/news/cameco-and-brookfield-sign-deal-with-u-s-government-to-help-build-reactors-ce7d5ddcda8cff24' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-28</td><td>0.35</td><td></td><td>Large contract wins</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Breakdown: Large contract wins or losses: The $80 billion nuclear reactor deal is a massive contract win. Assuming it represents a significant portion of Westinghouse's revenue (though the exact percentage isn's specified), this warrants a score of +0.3. Future revenue potential: The news explicitly mentions "substantial revenue and growth," indicating a positive outlook. This reinforces the positive impact of the contract win. The mention of "project execution and future contract announcements" introduces a slight element of uncertainty, preventing a higher score. --- <br> - Westinghouse securing an $80 billion nuclear reactor deal with the US government is a significant positive development, potentially driving substantial revenue and growth for the company. Investors should monitor project execution and future contract announcements. <br><br>*** REZUMAT *** - Westinghouse partners with US government. - Deal involves $80 billion for nuclear reactors. - Significant revenue potential for Westinghouse. - Project execution and future contracts are key.   (gemma3:12b-it-q4_K_M on 2025-10-29 00:31:53)</td><td><a href='https://www.proactiveinvestors.com/companies/news/1081261' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-28</td><td>0.30</td><td></td><td>Strategic partnerships or joint ventures</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Breakdown: Strategic partnerships or joint ventures: This is the most relevant event. The partnership with the US government, focused on accelerating reactor deployment and boosting uranium demand, suggests a clear synergy. This contributes a score of +0.3. Forward-looking impact: The news explicitly mentions "accelerated reactor deployment" and "increased demand," indicating a positive future outlook for Cameco and Brookfield. Low impact of other factors: The news doesn't mention any of the other negative events (lawsuits, debt restructuring, etc.) and focuses primarily on the partnership's potential benefits. --- <br> - This partnership signals strong government support for nuclear energy and could significantly benefit Cameco and Brookfield through accelerated reactor deployment and increased demand for uranium. Investors should monitor project progress. <br><br>*** REZUMAT *** - Cameco & Brookfield partner with US Government. - Focus: Accelerate Westinghouse nuclear reactor deployment. - Partnership aims to boost nuclear energy infrastructure. - Supports US clean energy goals and uranium demand.   (gemma3:12b-it-q4_K_M on 2025-10-29 00:15:28)</td><td><a href='https://www.joplinglobe.com/region/national_business/cameco-and-brookfield-establish-transformational-partnership-with-united-states-government-to-accelerate-deployment-of-westinghouse/article_bb1becd6-33fb-55c5-bd0a-ba5bb51d51c5.html' target='_blank'>Link</a></td></tr><tr class='pos-strong'><td>2025-10-28</td><td>0.80</td><td></td><td>Strategic partnership</td><td>0.80 GPT4 / 0.40 local feel              __   CCO.TO __    -> i:0.8<-                      <br><br>FEELING: 0.8 --- <br> - Cameco's stock surged 22.32% on news of an $80 billion strategic partnership with Brookfield and the U.S. government to accelerate nuclear reactor deployment. This deal positions Cameco as a key supplier and signals strong long-term growth potential for the company. <br><br>*** REZUMAT *** - Cameco (CCO/CCJ) stock up 22.32%, trading at $148.32. - $80 billion strategic partnership with Brookfield & U.S. government. - Partnership to accelerate Westinghouse nuclear reactor deployment. - U.S. government to provide financing & regulatory support. - Deal aims to revitalize U.S. & international nuclear supply chains. - Reactors to power U.S. grid, supporting AI infrastructure. - Cameco positioned as key supplier for Westinghouse technologies. - Announced October 28, 2025, in Saskatoon, Saskatchewan.   <br> <br>-- GPT4: +0.8, Buy, Strategic partnership boosts long-term growth potential.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-10-29 00:14:16)</td><td><a href='https://www.investorideas.com/news/2025/renewable-energy/10281-cameco-corporation-tsx-cco-nyse-ccj-surges-on-80-billion-us-nuclear-deal-with-brookfield-and-westinghouse.asp' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-28</td><td>0.30</td><td></td><td>quarterly earnings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                     **   ** 2025-07-31 **   <br><br>** 2025-07-31  quarterly earnings ***<br>FEELING: total score 0.3 Breakdown: Positive analyst ratings: +0.1 (Analysts maintaining "Buy" or "Outperform" ratings is a positive signal) Strong earnings beat: +0.2 (Q2 2024 EPS beat estimates is a significant positive) Positive outlook for 2025: +0.1 (Suggests continued growth potential) Institutional buying: +0.05 (Indicates investor confidence) Hedge fund increased holdings: +0.05 (Further reinforces investor confidence) Negative factors (low impact): Revenue slightly missed estimates: -0.05 (The impact is mitigated by the strong earnings beat and positive outlook) Backward-looking data: Very low score value. --- <br> - Cameco (CCJ) has reached a 52-week high, supported by positive analyst ratings and institutional buying. While revenue slightly missed estimates, the company's strong earnings beat and positive outlook for 2025 suggest continued growth potential. Investors should consider the valuation and monitor future earnings reports. <br><br>*** REZUMAT *** - CCJ reached a 52-week high at $104.30 on Tuesday, September 17, 2024. - Multiple analysts maintain "Buy" or "Outperform" ratings, with target prices around $102. - Q2 2024 EPS beat estimates at $0.51, compared to $0.29 expected. - Revenue was $467.72 million, slightly below the $819.79 million consensus estimate. - FY 2025 EPS guidance set, with analysts anticipating 1.27 EPS. - Institutional ownership stands at 70.21%, indicating strong investor confidence. - Hedge funds like Manchester Capital Management increased holdings by 100% in Q1. - Company operates in Uranium, Fuel Services, and Westinghouse segments.   (gemma3:12b-it-q4_K_M on 2025-10-29 00:24:38)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-nyseccj-hits-new-12-month-high-time-to-buy-2025-10-28/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-28</td><td>0.30</td><td></td><td>Strategic partnership</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Breakdown: Strategic partnerships or joint ventures: The partnership with Brookfield and the US Government is a significant strategic move. The phrasing "accelerate Westinghouse reactor technology deployment" and "revitalizing nuclear supply chains" suggests a clear synergy and potential for future growth. This contributes a score of +0.3. Shares up: The fact that shares are up $22.20 is a secondary indicator of positive sentiment, but the primary driver is the partnership itself. This reinforces the positive sentiment but doesn't significantly alter the core score. --- <br> - Cameco's partnership with Brookfield and the US Government to advance Westinghouse's nuclear technologies is a positive development, likely boosting demand and reinforcing its position in the nuclear energy sector. <br><br>*** REZUMAT *** - Cameco & Brookfield partner with US Government. - Partnership aims to accelerate Westinghouse reactor technology deployment. - Focus on revitalizing nuclear supply chains in US & globally. - Cameco shares up $22.20 to $143.46.   (gemma3:12b-it-q4_K_M on 2025-10-29 00:21:43)</td><td><a href='https://www.barchart.com/story/news/35730426/stocks-in-play-cameco-corporation' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-28</td><td>0.30</td><td></td><td>Strategic partnership</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Breakdown: Strategic partnerships or joint ventures: The partnership with Brookfield and the US Government is a significant strategic move. The phrasing "accelerate Westinghouse nuclear reactor deployment" and "revitalizing US and global nuclear supply chains" suggests a clear synergy and potential for growth. This contributes a score of +0.3. Stock Price Movement: The news is accompanied by a positive stock price movement ($22.20 increase). While not a direct financial event, it reflects market perception and adds a slight positive signal (+0.05). Other factors: The news doesn't directly relate to any other listed events. Promotional language and backward-looking data are minimal. --- <br> - Cameco's partnership with Brookfield and the US Government to advance Westinghouse's nuclear technologies is a positive development, likely boosting demand and reinforcing Cameco's position in the nuclear energy sector. <br><br>*** REZUMAT *** - Cameco & Brookfield partner with US Government. - Partnership aims to accelerate Westinghouse nuclear reactor deployment. - Focus on revitalizing US and global nuclear supply chains. - Cameco shares up $22.20 to $143.46.   (gemma3:12b-it-q4_K_M on 2025-10-29 00:34:45)</td><td><a href='https://www.theglobeandmail.com/investing/markets/stocks/CCO-T/pressreleases/35730427/stocks-in-play-cameco-corporation/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-28</td><td>0.30</td><td></td><td>Strategic partnership/joint venture</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score +0.3 Reasoning: Strategic partnerships or joint ventures: The partnership with the U.S. government and Westinghouse, backed by $80 billion, is a significant strategic partnership. The clear synergy of supporting U.S. energy infrastructure and AI development warrants a +0.3 score. Analyst meetings: The "Buy" rating and C$129.00 price target from an analyst contribute a small positive impact (+0.05). High P/E ratio: The mention of a high P/E ratio suggesting potential overvaluation introduces a slight negative sentiment (-0.05), partially offsetting the positive aspects. The rest of the news is either backward-looking data or promotional language, receiving very low absolute score values. --- <br> - Cameco's partnership with the U.S. government and Westinghouse, backed by $80 billion, signals strong growth potential in the nuclear sector. While valuation concerns exist, the company's strategic positioning and robust financials suggest a positive outlook for investors. <br><br>*** REZUMAT *** - Cameco partners with U.S. Government & Westinghouse in $80B nuclear initiative. - Initiative aims to build new reactors using Westinghouse technology. - Collaboration supports U.S. energy infrastructure & AI development. - Analyst rating: Buy, with a C$129.00 price target. - TipRanks AI Analyst rates CCO as Outperform. - High P/E ratio suggests potential overvaluation. - Company's market cap is C$53.72B. - Average trading volume: 1,315,867.   (gemma3:12b-it-q4_K_M on 2025-10-29 00:25:56)</td><td><a href='https://www.tipranks.com/news/company-announcements/cameco-joins-u-s-government-and-partners-in-80-billion-nuclear-power-initiative' target='_blank'>Link</a></td></tr><tr class='pos-strong'><td>2025-10-28</td><td>0.80</td><td></td><td>Strategic partnerships or joint ventures</td><td>event_TBD 0.80 GPT4 / 0.60 local feel              __   CCO.TO __    -> i:0.8<-                      <br><br>FEELING: 0.8 --- <br> - Cameco's stock surged over 20% on an $80 billion U.S. nuclear reactor deal with Brookfield. This partnership signals strong growth potential for Cameco and Westinghouse, driven by increased demand and U.S. government support. <br><br>*** REZUMAT *** - Cameco shares rose over 20%, trading at $146.62. - Brookfield and Cameco secured $80 billion U.S. nuclear reactor deal. - U.S. government to facilitate permitting and financing for reactors. - Westinghouse acquisition occurred in November 2023. - U.S. government to receive 20% of cash distributions above $17.5 billion. - Final investment decision needed for U.S. government's participation.   <br> <br>-- GPT4: +0.8, Buy, Major deal boosts growth potential and demand.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-10-29 00:27:39)</td><td><a href='https://www.theglobeandmail.com/business/international-business/us-business/article-westinghouse-cameco-and-brookfield-partner-with-us-government-on-80/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-28</td><td>0.30</td><td>1167</td><td>Strategic partnership / joint venture</td><td>0.30 GPT4 / 0.40 local feel              __   CCO.TO __    -> i:0.3<-                     **   ** 2029-01-31 **   <br><br>** 2029-01-31  Strategic partnership / joint venture ***<br>FEELING: 0.3 --- <br> - This partnership represents a significant catalyst for Cameco and Westinghouse, backed by substantial US government investment. Investors should anticipate increased demand for Cameco's uranium and nuclear fuel services, though potential risks related to regulatory approvals and financing should be monitored. <br><br>*** REZUMAT *** - Cameco and Brookfield formed a strategic partnership with the US Government for Westinghouse nuclear reactor deployment. - US Government to arrange financing and facilitate approvals for new reactors, with at least US$80 billion investment. - Partnership aims to accelerate global deployment of Westinghouse reactor technologies and revitalize US nuclear supply chains. - US Government will receive 20% of cash distributions above US$17.5 billion. - Westinghouse could be subject to an IPO if valuation reaches US$30 billion by January 2029. - Brookfield and Cameco acquired Westinghouse in November 2023. - Partnership involves potential risks related to regulatory approvals and financing.   <br> <br>-- GPT4: +0.3, Hold, Positive partnership news boosts demand but watch regulatory risks.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-10-29 00:29:18)</td><td><a href='https://www.businesswire.com/news/home/20251027861514/en/Cameco-and-Brookfield-Establish-Transformational-Partnership-With-United-States-Government-to-Accelerate-Deployment-of-Westinghouse-Nuclear-Reactors' target='_blank'>Link</a></td></tr><tr class='pos-strong'><td>2025-10-28</td><td>0.80</td><td>1137</td><td>Strategic partnership</td><td>0.80 GPT4 / 0.60 local feel              __   CCO.TO __    -> i:0.8<-                     **   ** 2029-01-01 **   <br><br>** 2029-01-01  Strategic partnership ***<br>FEELING: 0.8 --- <br> - Cameco's stock surged 20% on a significant U.S. government partnership to accelerate nuclear reactor deployment, potentially boosting demand for uranium fuel and driving long-term growth. Investors should monitor Westinghouse project milestones. <br><br>*** REZUMAT *** - Cameco [CCO-TSX, CCJ-NYSE] up 20% on U.S. government nuclear deal. - Partnership with Brookfield to deploy Westinghouse reactor technologies. - U.S. government to arrange financing & facilitate approvals. - Project creates/sustains 45,000 jobs in 43 states. - Total investment: minimum US$80 billion for new reactors. - U.S. government gets 20% of cash distributions > $17.5B. - IPO possible if Westinghouse valuation ≥ $30 billion by 2029. - Cameco is a major uranium fuel provider. - Reserves: 469 million pounds of proven/probable mineral reserves.   <br> <br>-- GPT4: +0.8, Buy, U.S. partnership boosts demand and growth potential for Cameco.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-10-29 00:30:42)</td><td><a href='https://resourceworld.com/cameco-up-20-on-nuclear-power-deal-with-u-s-government/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-28</td><td>0.30</td><td></td><td>Large contract wins</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Reasoning: The news highlights a partnership with the US government for nuclear reactor fuel supply. This falls under "strategic partnerships or joint ventures" where synergy is clear. The partnership is expected to boost investor confidence and potentially drive stock appreciation. This indicates a positive impact on future performance and investor sentiment, justifying a score of +0.3. The language used ("significant positive catalyst," "boosting investor confidence," "potential for stock price increase") suggests a tangible, forward-looking benefit. --- <br> - Cameco's partnership with the US government for nuclear reactor fuel is a significant positive catalyst, likely boosting investor confidence and potentially driving further stock appreciation. <br><br>*** REZUMAT *** - Cameco partners with US government. - Focus on nuclear reactor fuel supply. - Partnership boosts investor confidence. - Potential for stock price increase.   (gemma3:12b-it-q4_K_M on 2025-10-29 00:56:09)</td><td><a href='https://www.investing.com/news/stock-market-news/cameco-stock-soars-after-us-government-nuclear-reactor-partnership-93CH-4312991' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-27</td><td>0.35</td><td></td><td>quarterly earnings</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Rationale: Here's a breakdown of the scoring based on the provided news and the defined events: Institutional Investor Activity (New Stakes & Increased Holdings): +0.3 - Significant increases in holdings by multiple institutional investors strongly suggest positive sentiment and confidence in the company's future prospects. This is a key indicator of institutional support. EPS Beat: +0.1 - Beating EPS expectations is a positive signal, indicating better-than-expected profitability. Revenue Miss: -0.05 - While revenue missed estimates, the overall positive sentiment from institutional buying and EPS beat mitigates the negative impact. FY 2025 EPS Guidance: +0.05 - Setting FY 2025 EPS guidance is a positive sign, demonstrating management's confidence in future performance. Analyst Ratings: 0 - While analysts maintain "Buy" or "Outperform" ratings, this is a standard observation and doesn't carry significant weight unless there's a clear consensus across all analysts. Backward-Looking Data/Promotional Language: 0 - The 1-year range and past performance data are largely ignored as they are not forward-looking. The overall score reflects the dominant positive influence of institutional buying and the EPS beat, slightly offset by the revenue miss. --- <br> - Cameco (CCJ) is experiencing significant positive attention from institutional investors, with multiple firms increasing their holdings. While revenue fell short of estimates, the company beat EPS expectations and demonstrated strong year-over-year growth. Analyst ratings remain largely positive, suggesting a potential for continued upward momentum. <br><br>*** REZUMAT *** - Pasadena Private Wealth LLC initiated a new stake in CCJ, valued at $236,000. - Bison Wealth LLC increased its stake by 16.1% to 21,448 shares ($1,102,000). - Wealth Enhancement Advisory Services increased holdings by 30.4% to 8,183 shares ($337,000). - Cambridge Investment Research Advisors increased stake by 4.2% to 75,031 shares ($3,088,000). - Mirae Asset Global Investments increased stake by 159.0% to 60,648 shares ($2,496,000). - Sumitomo Mitsui Trust Group increased stake by 18.9% to 560,642 shares ($23,076,000). - Institutional investors own 70.21% of CCJ's stock. - CCJ stock opened at $88.11, with a 1-year range of $35.00 - $97.79. - Q3 revenue was $467.72 million, below the $819.79 million estimate. - CCJ reported $0.51 EPS, beating the $0.29 estimate by $0.22. - FY 2025 EPS guidance was set. - Analysts predict 1.27 EPS for the current fiscal year. - Multiple analysts maintain "Buy" or "Outperform" ratings.   (gemma3:12b-it-q4_K_M on 2025-10-27 21:51:12)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-pasadena-private-wealth-llc-takes-position-in-cameco-corporation-ccj-2025-10-27/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-26</td><td>0.35</td><td></td><td>quarterly earnings</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Breakdown: Institutional Buying Interest: +0.2 (Significant institutional buying is a positive signal of confidence, indicating potential for future price appreciation. The fact that multiple firms increased their stakes strengthens this signal.) EPS Above Expectations: +0.1 (Exceeding EPS expectations is a positive surprise, reflecting better-than-expected profitability. This is a key driver for stock value.) Analyst Consensus Price Target: +0.05 (While analyst ratings generally receive a low score, a consensus price target suggests a level of agreement among analysts, adding a slight positive influence.) Revenue Below Estimates: -0.05 (Falling short of revenue estimates is a negative, offsetting some of the positive signals. However, the EPS beat mitigates the impact.) FY 2025 Guidance: +0.05 (The mention of FY 2025 guidance suggests forward-looking information, which is valuable for investors.) Note: The year-over-year revenue increase is backward-looking data and receives a very low score. --- <br> - Cameco (CCJ) is experiencing significant institutional buying interest, with multiple firms increasing their stakes. While recent revenue fell short of estimates, the company exceeded EPS expectations and boasts positive analyst ratings and a consensus price target around $89.55. Investors should monitor future earnings reports and revenue performance. <br><br>*** REZUMAT *** - Envestnet Portfolio Solutions Inc. invested $202,000 in Cameco (CCJ) in Q2. - Bison Wealth LLC increased stake by 16.1% ($1,102,000) in Q4. - Wealth Enhancement Advisory Services boosted stake by 30.4% ($337,000) in Q1. - Cambridge Investment Research Advisors increased stake by 4.2% ($3,088,000) in Q1. - Sequoia Financial Advisors increased stake by 6.2% ($3,414,000) in Q1. - Mirae Asset Global Investments increased stake by 159.0% ($2,496,000) in Q1. - 70.21% of CCJ stock is held by institutional investors. - CCJ opened at $88.11 on Friday, with a 52-week range of $35.00 - $97.79. - Cameco reported $0.51 EPS, exceeding estimates of $0.29 on $467.72 million revenue. - Revenue increased 46.7% year-over-year. - Cameco's FY 2025 guidance includes EPS. - Analyst consensus price target is $89.55.   (gemma3:12b-it-q4_K_M on 2025-10-26 21:08:20)</td><td><a href='https://www.defenseworld.net/2025/10/26/envestnet-portfolio-solutions-inc-makes-new-202000-investment-in-cameco-corporation-ccj.html' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-26</td><td>0.30</td><td></td><td>Strategic partnerships/joint ventures</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Breakdown: quarterly or annual results: Not explicitly mentioned, so 0. major dividend change: Not mentioned, so 0. mergers/acquisitions: Not mentioned, so 0. management changes: Not mentioned, so 0. guidance updates: Implicitly positive due to "future profits expected to soar," +0.2 stock splits: Not mentioned, so 0. share consolidations: Not mentioned, so 0. lawsuits: Not mentioned, so 0. accretive to DCF per share: Implicitly positive due to "future profits expected to soar," +0.3 debt restructuring / renegotiation: Not mentioned, so 0. credit rating changes: Not mentioned, so 0. buyback programs: Not mentioned, so 0. FDA or Canada Health decisions: Not applicable. product launches: Not applicable. capital raises: Not applicable. bankruptcy filings or Chapter 11 protection: Not applicable. strategic partnerships or joint ventures: Not applicable. analyst meetings: Low score, as it's a general assessment, -0.1 large contract wins or losses: Not applicable. cybersecurity incidents / data breaches: Not applicable. major political actions like war or major strikes: Not applicable. regulatory changes: Not applicable. Uranium demand surge expected through 2045: +0.1 (long-term demand outlook) High P/E ratio (100.7x): -0.1 (indicates high growth expectations, but also potential risk) Project delays & operational challenges: -0.1 (risk factor) Rationale: The news primarily focuses on future demand and valuation. The "fairly valued" assessment is neutral. The high P/E ratio and operational challenges introduce some risk, but the long-term demand outlook and implicit future profit growth are positive. The YTD and total shareholder return figures are backward-looking and receive a low score. --- <br> - Cameco's valuation is currently "fairly valued" with a fair value estimate of $124.81, reflecting optimism about future uranium demand. Investors should monitor project approvals and operational challenges, as the high P/E ratio (100.7x) indicates significant growth expectations. <br><br>*** REZUMAT *** - Cameco (CCO) valuation in focus due to U.S. nuclear project restart. - Stock up 64% YTD, 65% total shareholder return (one year). - Three-year total return: 277%, reflecting renewed investor enthusiasm. - Fair value estimate: $124.81, with cautious optimism. - P/E ratio: 100.7x, significantly higher than industry averages. - Future profits expected to soar, driving margin boost. - Project delays & operational challenges pose a risk. - Uranium demand surge expected through 2045.   (gemma3:12b-it-q4_K_M on 2025-10-26 21:05:48)</td><td><a href='https://simplywall.st/stocks/ca/energy/tsx-cco/cameco-shares/news/cameco-tsxcco-valuation-in-focus-following-major-us-nuclear' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-25</td><td>0.35</td><td></td><td>quarterly earnings</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score 0.35 Breakdown: Institutional Investor Activity: Several institutional investors increasing their stakes (8.1%, 0.4%, 2.4%, 1.0%, 0.5%, 1.8%) indicates positive sentiment and confidence. (+0.3) EPS Beat: Cameco reported $0.51 EPS, beating estimates by $0.22. (+0.2) Analyst Ratings: Positive analyst ratings and a consensus "Buy" rating suggest continued optimism. (+0.1) FY 2025 Guidance: Analysts anticipate 1.27 EPS for FY 2025, indicating a positive outlook. (+0.1) Revenue Miss: Revenue fell short of estimates (-$352.07 million). (-0.1) Consensus Target Price: Consensus target price is $89.55 with a "Buy" rating. (+0.05) Note: The revenue miss slightly offsets the positive signals, but the overall sentiment remains cautiously optimistic due to the institutional buying and positive guidance. --- <br> - Cameco (CCJ) is experiencing increased interest from institutional investors, with several boosting their stakes. Positive analyst ratings and a consensus "Buy" rating suggest continued optimism. While revenue fell short of estimates, the company's strong uranium business and positive outlook for FY 2025 warrant a cautiously optimistic view. <br><br>*** REZUMAT *** - Cwm LLC increased its stake in Cameco (CCJ) by 8.1% during Q2. - Hager Investment Management Services LLC lifted holdings by 0.4% during Q2. - Signaturefd LLC increased stake by 2.4% during Q2. - Belpointe Asset Management LLC boosted position by 1.0% during Q2. - Country Club Bank increased stake by 0.5% during Q1. - Sunpointe LLC grew stake by 1.8% during Q1. - Institutional investors own 70.21% of Cameco's stock. - CCJ stock has a 52-week range of $35.00 - $97.79. - Cameco reported $0.51 EPS, beating estimates by $0.22. - Revenue was $467.72 million, below estimated $819.79 million. - FY 2025 guidance set, analysts anticipate 1.27 EPS. - Several analysts reaffirmed "Buy" or "Outperform" ratings. - Consensus target price is $89.55 with a "Buy" rating.   (gemma3:12b-it-q4_K_M on 2025-10-25 21:35:40)</td><td><a href='https://www.defenseworld.net/2025/10/25/cwm-llc-has-509000-stake-in-cameco-corporation-ccj.html' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-25</td><td>0.30</td><td></td><td>quarterly earnings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Rationale: Increased institutional investment: This indicates positive sentiment and confidence in the company's future, contributing +0.2. Positive analyst ratings: "Outperform" or "buy" ratings and a target price suggest a bullish outlook, adding +0.1. Beat EPS expectations: This is a significant positive, contributing +0.2. Revenue missed estimates: This is a negative, but the EPS beat somewhat offsets it. -0.1 FY 2025 EPS guidance: The expectation of 1.27 EPS is a positive forward-looking indicator, adding +0.1. Backward-looking data: The mention of past year trends and the stock price on Friday are given very low weight. Analyst ratings: While positive, the rating itself doesn't carry much weight unless there's a clear consensus. --- <br> - Cameco (CCJ) is experiencing increased institutional investment and positive analyst ratings, suggesting a bullish outlook. While revenue missed estimates, the company beat EPS expectations and demonstrated strong year-over-year growth, indicating potential for future success. <br><br>*** REZUMAT *** - Brian Low Financial Group invested $850,000 in Cameco (CCJ) in Q2. - Hager Investment Management Services LLC owns $2,274,000 worth of shares. - Signaturefd LLC boosted stake by 2.4%, now owns $603,000 worth. - Belpointe Asset Management LLC owns $1,623,000 worth of shares, up 1.0%. - Country Club Bank owns $1,822,000 worth, increased by 0.5%. - Blume Capital Management Inc. raised holdings by 2.2%, now owns $992,000. - 70.21% of stock owned by institutional investors and hedge funds. - Analysts maintain "outperform" or "buy" ratings, target price $89.55. - CCJ opened at $88.11 on Friday, market cap $38.36 billion. - Q3 EPS $0.51 beat estimates by $0.22, revenue $467.72 million. - FY 2025 EPS guidance set, analysts expect 1.27 EPS.   (gemma3:12b-it-q4_K_M on 2025-10-25 21:32:41)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-brian-low-financial-group-llc-makes-new-850000-investment-in-cameco-corporation-ccj-2025-10-25/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-25</td><td>0.30</td><td></td><td>quarterly earnings</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Reasoning: Here's a breakdown of the score based on the provided news and the defined events: quarterly or annual results: The company beat EPS expectations (+0.2), but missed revenue estimates (-0.1). The net effect is slightly positive. analyst meetings: Analysts maintain a "Buy" rating (+0.1). institutional investor interest: Increased institutional investor interest is generally a positive sign (+0.1). The specific details of individual firms buying/selling shares are less impactful. guidance updates: FY 2025 EPS guidance is mentioned, which is a forward-looking element (+0.1). buyback programs: No mention of buybacks. analyst target price: The consensus target price is slightly above the current price, which is a minor positive (+0.05). The negative aspects (missed revenue) are offset by the positive signals from EPS beat, institutional buying, and analyst ratings. The overall impact is mildly positive. --- <br> - Cameco (CCJ) is experiencing increased institutional investor interest, with several firms raising their positions. While the recent quarterly revenue missed estimates, the company beat EPS expectations and demonstrated year-over-year revenue growth. Analysts maintain a "Buy" rating, suggesting potential for future gains. <br><br>*** REZUMAT *** - PKO Investment Management sold 3,400 shares, reducing holdings by 22.7% in Q2. - Bison Wealth LLC increased its stake by 16.1%, owning 21,448 shares. - Wealth Enhancement Advisory Services grew holdings by 30.4%, now owning 8,183 shares. - Cambridge Investment Research Advisors raised position by 4.2%, owning 75,031 shares. - Moran Wealth Management lifted stake by 11.2%, now owning 48,636 shares. - Sequoia Financial Advisors increased stake by 6.2%, owning 82,939 shares. - 70.21% of stock owned by institutional investors. - Analysts maintain a "Buy" rating with a consensus target price of $89.55. - CCJ opened at $88.11 on Friday, with a market cap of $38.36 billion. - Q3 EPS of $0.51 beat estimates by $0.22; revenue of $467.72 million missed estimates. - FY 2025 guidance set; analysts expect EPS of 1.27 for the current year.   (gemma3:12b-it-q4_K_M on 2025-10-25 21:31:15)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-pko-investment-management-joint-stock-co-sells-3400-shares-of-cameco-corporation-ccj-2025-10-25/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-23</td><td>0.35</td><td></td><td>quarterly earnings</td><td>0.35 local feel              __   CCO.TO __    -> i:0.35<-                      <br><br>FEELING: total score +0.35 Breakdown: Analyst meetings: Target price increase to $110 by Royal Bank of Canada (+0.1) and maintained "Buy" and "Outperform" ratings (+0.1). quarterly or annual results: Beat EPS estimates (+0.2). Revenue fell short of expectations, which slightly offsets the positive EPS beat (-0.05). Institutional buying: Significant institutional buying (Norges Bank, Alliancebernstein, Canada Pension Plan Investment Board) (+0.1). Forward-looking growth: Mention of "potential for future growth in the nuclear sector" (+0.05). Backward-looking data/promotional language: The Y/Y revenue and EPS increases, and the general promotional language are given very low weight. --- <br> - Cameco (CCJ) experienced a 3.2% stock price increase, driven by positive analyst ratings and significant institutional buying. While revenue fell short of expectations, the company beat EPS estimates and demonstrated strong year-over-year growth. Investors should consider the positive momentum and potential for future growth in the nuclear sector. <br><br>*** REZUMAT *** - CCJ stock up 3.2% to $86.23, trading volume down 8% from average. - Target price increased to $110 by Royal Bank of Canada (August 1st). - Analysts maintain "Buy" and "Outperform" ratings, consensus target $89.55. - 50-day moving average: $81.62, 200-day: $68.25. - Q3 EPS: $0.51, beating estimates by $0.22; revenue $467.72M vs $819.79M expected. - Y/Y revenue up 46.7%, EPS up from $0.14. - Norges Bank purchased $341.7M stake, Alliancebernstein boosted stake by 39.3%. - Canada Pension Plan Investment Board increased stake by 215.7%. - Institutional investors own 70.21% of outstanding shares.   (gemma3:12b-it-q4_K_M on 2025-10-23 23:36:18)</td><td><a href='https://www.marketbeat.com/instant-alerts/cameco-nyseccj-stock-price-up-32-time-to-buy-2025-10-23/' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-23</td><td>0.30</td><td></td><td>Strategic partnerships or joint ventures</td><td>0.3 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: total score 0.3 Reasoning: The news primarily revolves around a Canadian government investment in a small-modular nuclear project. This falls under the category of "strategic partnerships or joint ventures" where synergy is clear. The government investment signals support and potential for further investment, which is a positive sign. Strategic partnerships or joint ventures (synergy is clear): +0.3 The mention of "project milestones and regulatory approvals" indicates a forward-looking aspect, suggesting potential future value. However, the outcome is still dependent on these approvals, so the score isn't significantly higher. No other events listed are directly applicable. --- <br> - This Canadian government investment signals strong support for small-modular nuclear technology, potentially boosting the project's viability and attracting further investment. Investors should monitor project milestones and regulatory approvals. <br><br>*** REZUMAT *** - Canada acquires 15% stake. - Focuses on Toronto-area small-modular nuclear project. - Supports nuclear technology development. - Project aims to advance clean energy solutions.   (gemma3:12b-it-q4_K_M on 2025-10-23 23:35:00)</td><td><a href='https://news.futunn.com/en/post/63711238/canada-to-acquire-15-stake-in-toronto-area-small-modular' target='_blank'>Link</a></td></tr><tr class='pos-light'><td>2025-10-23</td><td>0.30</td><td></td><td>quarterly earnings</td><td>0.30 GPT4 / 0.45 local feel              __   CCO.TO __    -> i:0.3<-                      <br><br>FEELING: 0.3 --- <br> - Cameco (CCJ) is experiencing increased institutional interest, with several firms acquiring new stakes. Positive analyst ratings and price target revisions suggest a bullish outlook. While recent revenue fell short of estimates, the company's strong EPS beat and overall positive momentum warrant consideration for investors. <br><br>*** REZUMAT *** - International Assets Investment Management LLC bought 3,818 shares ($283,000) in Q2. - Trust Co. of Vermont increased holdings by 1,029.4% (350 shares, $29,000). - Hilltop National Bank acquired a new position worth $30,000 in Q2. - Atticus Wealth Management LLC acquired a new position worth $34,000 in Q2. - Manchester Capital Management LLC increased holdings by 100% (300 shares, $25,000). - Dagco Inc. acquired a new position worth $28,000 in Q1. - 70.21% of stock owned by institutional investors and hedge funds. - Wall Street Zen upgraded from "hold" to "buy." - CLSA issued an "outperform" rating with a $102.00 price target (Sept 9). - UBS Group set a $102.00 price target (Sept 9). - RBC raised price target from $100.00 to $110.00 (Aug 1). - Average analyst rating is "Buy" with a target price of $89.55. - Stock opened at $83.52 on Thursday. - 52 week low: $35.00, 52 week high: $97.79. - Q3 EPS: $0.51 (beat estimate of $0.29). - Revenue: $467.72 million (missed estimate of $819.79 million). - Revenue up 46.7% year-over-year. - FY 2025 guidance set. - Analysts forecast EPS of 1.27 for the current year.   <br> <br>-- GPT4: +0.3, Buy, Institutional interest and positive ratings boost outlook despite revenue miss.   (GPT4o +++ gemma3:12b-it-q4_K_M on 2025-10-23 23:33:56)</td><td><a href='https://www.marketbeat.com/instant-alerts/filing-international-assets-investment-management-llc-buys-new-stake-in-cameco-corporation-ccj-2025-10-23/' target='_blank'>Link</a></td></tr></table></div></div>
    </div>
    </body>
    </html>
    